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ABSTRACT 
 
This white paper provides basic ethical guidelines for treating patients with 
suspected or confirmed coronavirus disease (COVID-19). It responds to the need from 
healthcare organizations to address the moral considerations inherent to caring for this 
patient population, particularly in the context of scarce resource allocation, the imposition 
of limits to individual freedoms, and ​de facto​ social distancing. These guidelines are not 
narrowly prescriptive, but recognize the need of decision makers to transform this 
guidance into specific decisions. Ethical decision making assumes that such judgments 
will be based on current scientific knowledge, that effectiveness of interventions is 
carefully assessed, and that transparency of the process is evident. As specific decisions 
are considered, processes should be in place for identifying which ethical issues were 
addressed, how guidelines were used, how decisions affected the community, and what 
lessons can be shared with other decision makers. In this way, these guidelines will 
continue to be an interactive, working document. 
 
Keywords:​ COVID-19; Ethical Guidelines; Crisis Standards of Care; Public Health 
Emergency; Scarce Resource Allocation; Disaster Bioethics 
 
1. BACKGROUND AND OBJECTIVES 
 
1.1 The Role of Ethics in Pandemic Planning 
 
One characteristic of public health crises is that health needs overwhelm available 
human and material resources. Difficult decisions must be made about how, where, and 
to whom resources should be allocated. Medical science provides valuable information to 
help make these decisions, but science alone is insufficient. As some scholars have 
pointed out, pandemic planning needs to take ethical considerations seriously, and not 
allow the urgency of logistical and scientific needs to sideline a discussion of ethical 
considerations.​1-3​ It is important to make these presuppositions explicit because the costs 
of not addressing the ethical concerns are severe: loss of public trust, low hospital staff 
morale, confusion about roles and responsibilities, stigmatization of vulnerable 
communities, and misinformation.​4  
 
Another key insight that we overlook at our peril is that, in times of crisis, where 
guidance is incomplete, consequences uncertain, and information constantly changing -- 
where hour-by-hour decisions involve life and death -- fairness is more important, rather 
than less.​5​ As this paper suggests, fairness considerations are both procedurally and 
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 substantively important: there is a need for fair decision-making processes, as well as 
equitable distributions of scarce human and material resources. Take, for example, the 
triaging of ventilated beds in an intensive care unit (ICU). In theory, decision makers rely 
on scientific evidence to determine how best to maximize benefit in the allocation of 
ventilated beds, but science cannot tell us whether the initial decision to maximize benefit 
is just. Insofar as maximizing benefit is derived from a reflection on values, ethical 
analysis is required to determine why a utilitarian approach to triage though 
maximization of benefit is preferable to the assignment of ventilated beds on a different 
basis -- for instance, that of greatest need.​1 
 
The importance of ethics to pandemic planning is in the application of value 
judgements to science,​ ​especially as they are embedded in planning assumptions, and 
within the practice of medicine itself. While ethics might have little to contribute to 
understanding the mechanism of COVID-19 transmission, it can make a significant 
contribution to debates such as what levels of harm the public are prepared to accept, how 
the burdens of negative outcomes should be distributed across the population, and 
whether more resources should be invested in stockpiling a certain preventative measure. 
The use of ethical frameworks to guide decision making may help to mitigate some of the 
unintended and unavoidable collateral damage from a local COVID-19 outbreak. As Jaro 
Kotalik argues, the incorporation of ethics into pandemic plans can help to make them 
instruments for building mutual trust and solidarity at such time that will likely present a 
major challenge to our societies.​2​ Using ethical frameworks to help guide decisions can 
offer greater assurance that the values instantiated within them -- such as accountability, 
transparency and trust -- will be carefully thought about in decision making and when 
reviewing decisions with stakeholders. 
 
The ethics literature on bioterrorism and battlefield triage informs our thinking 
here, and calls our attention to important issues such as the duty to care, reciprocity, 
equity, and good stewardship.​6-11​ The importance of having ethically robust criteria and 
policies developed in advance of a pandemic COVID-19 outbreak is underscored in this 
literature,​12-16​ which makes clear that critical decisions like these should not be made on 
an individual, case-by-case basis, and that clinicians should never be placed in a position 
of individually deciding to deny treatment to patients without the guidance of policy or 
protocol.​8​ Robust disaster preparedness requires practicing preventive ethics.​4  
 
1.2 Objectives 
Preparing for and responding to COVID-19 raises numerous ethical issues: Who 
should receive priority for limited resources? How should decisions be made that would 
limit civil liberties? How and when should information be provided to the public? How 
should the needs of vulnerable populations be addressed?​17​ What standards of care would 
be expected when staff, equipment, and medications are insufficient to meet the demand 
and to provide the level of medical care that is expected during non-emergency times? 
2 
 What guidance could be made available to clinicians to assist them in making fair and 
responsible decisions under these circumstances?​18 
 Exploring the foundations of such issues and proposing general methodological 
guidelines is the objective of this paper. Its rationale is based on the attention given to 
altered standards of care (ASC) in 2004, when the Massachusetts Statewide Surge 
Committee, under the supervision of the Massachusetts Department of Public Health 
(MPDH), engaged in pandemic influenza planning. In January 2006, MDPH and the 
Harvard School of Public Health Center for Public Health Preparedness (HSPH-CPHP) 
worked together to make recommendations to the Commonwealth on the major ethical, 
legal, and practical issues regarding ASC during influenza pandemic. To ensure equity 
and consistency and to relieve burdens on individual clinicians, a 20-member Joint 
Working Group comprised of ethicists, lawyers, clinicians, and local and state public 
health officials determined that guidelines for decision making must be developed at the 
state level, as opposed to the local or institutional level. To this end, the group recognized 
the importance of including a range of key stakeholders in the decision making process 
and ensuring transparency by making public the process and rationale.​17 
2. GUIDING GOALS AND PRINCIPLES 
2.1 Guiding Goals 
Donna Levin and colleagues identify four public health goals to inform and direct 
the allocation of limited resources.​17​ Building on their work, the following is 
recommended for application in the context of COVID-19 outbreak. 
1. Control the outbreak to the extent possible by protecting the public from mass 
infection and resultant morbidity and mortality. 
2. Maximize positive patient outcomes when healthcare needs exceed available 
resources, utilizing a physiological score such as that delineated in the Utah 
Model (see Appendix A).  
3. Establish principles and guidelines to assist clinicians to continue to provide care 
in an ethical manner during circumstances that make delivery of healthcare 
services in the normal course difficult, if not impossible. 
4. Establish processes directed by Massachusetts Department of Public Health 
(MDPH) for determining priorities for the use of limited healthcare resources and 
to establish altered standards of care (ASC) and clinical protocols for clinicians at 
all levels across healthcare organizations. 
2.2 Primary Guiding Principles 
To ensure that the foregoing goals are accomplished in an ethical manner, the following 
seven guiding principles are recommended for application in the context of COVID-19 
outbreak. 
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 1. Limited resources should be allocated so as to maximize the number of lives 
saved ​(determined on the basis of the best medical information, implemented in 
a manner that provides equitable treatment of any individual or group of 
individuals based on the best available clinical knowledge and judgment, and 
implemented​ without discrimination or regard to sex, sexual orientation, 
race, religion, ethnicity, disability, age, income, or insurance status​). Age 
and/or disability may be considered along with other risk factors in allocating 
resources to save as many lives as possible, but the importance of saving older 
adults or people with disabilities is the same as for others. The assessment of risk 
factors should be made on the basis of the best medical information, clinical 
knowledge, and clinical judgment. This principle ensures that people are not 
denied medical care based solely on their age or disability. It does allow for the 
consideration of risk factors, however, based on the individual’s medical 
condition. This medical condition can be the consequence of the aging process or 
of a particular disability and could affect the individual’s ability to benefit from, 
withstand, and survive the scarce medical intervention needed by others. This 
consideration is in conformance with the overarching principle of maximizing 
the number of lives saved. Note that there is no inclusion of the “fair innings 
principle” (see 3.10), although similar ethical concepts may be considered and 
included as the guidelines evolve.  
2. ASC​ protocols should permit flexibility for physician discretion​, exercised in 
good faith, under circumstances that warrant exception from the protocols and 
subject to prior expedited review process. Healthcare organizations should 
establish capacity for expeditious review of exceptions.  
3. Healthcare organizations will be responsible for ​developing mutual aid plans ​in 
partnership with regional healthcare institutions to secure a uniform approach to 
the pandemic. 
4. ASC ​protocols should recognize any changes in practice necessary to 
provide care ​under conditions of scarce resources or overwhelming demand for 
care; an expanded scope of practice for clinicians; the use of alternate care sites, 
such as specialty care units at facilities other than hospitals; and reasonable, 
practical standards for documentation of delivery of care.  
5. Clinicians will be responsible for adhering to the protocols to ​protect the 
public’s health. 
6. Patient ​care should be provided within the context and limitations 
necessitated by the public health emergency. 
7. Healthcare organizations should ​prioritize the care and protection of its 
clinicians. 
 
3. RELEVANT ETHICAL THEORIES AND PRINCIPLES 
 
Several ethical theories and principles bear on the realization of the goals 
and principles delineated above, and serve to inform clinical practice. 
 
3.1 Utilitarianism 
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Utilitarianism commonly and popularly means producing the greatest happiness 
for the greatest number of people. Historically, allocation decisions in public health have 
been driven by the utilitarian goal of accomplishing the “greatest good for the greatest 
number.” Though utilitarianism can be interpreted many ways, it is difficult to imagine 
its scope, in the context of a public health crisis, as encompassing more than the narrow 
consideration of maximizing the numerical amount of persons who will survive to 
hospital discharge. However widely accepted the utilitarian rule may be during a public 
health emergency, it cannot stand on its own. Ethically, using only chance of survival to 
hospital discharge is insufficient because it rests on a thin conception of “accomplishing 
the greatest good.”​19​ Though this principle has some strengths -- namely, being aimed at 
beneficence,​ ​and having as its goal the promotion of general welfare -- what it clearly 
lacks is an understanding of justice.​ ​Utilitarianism permits the interests of the majority to 
override the rights of minorities, and does not have the resources to adequately guard 
against unjust social distributions.​20 
 
3.2 Justice 
 
Utilitarian theory, if it is to be exercised licitly in the context of pandemic 
COVID-19, must be tempered by a proper understanding and practice of justice. 
Common to all theories of justice is a minimal requirement attributed to Aristotle: 
Equals must be treated equally, and unequals must be treated unequally. Yet this 
principle identifies no particular respect in which equals ought to be treated equally and 
provides no criteria for determining whether two or more individuals are, in fact, equal. 
This vagueness is, at one and the same time, the theory’s virtue and its vice. On the one 
hand, it leaves the room necessary for an adequate interpretation and judgment of 
actions, circumstances, and intentions in an ever-changing world. On the other hand, it 
leaves to the imperfection of human judgment the enormous task of attributing value 
where it sees reasonably fit. Virtually all accounts of justice in healthcare hold that 
delivery programs and services designed to assist persons of a certain class, such as the 
poor, the elderly, or the disabled should be made available to all members of ​that class. 
To deny benefits to some when others in the same class receive benefits is unjust. But is 
it also unjust to deny access to equally needy persons outside of the delineated class?​20  
 A proper understanding and practice of justice assures that persons be treated 
fairly, that vulnerable populations are protected, and that each person is treated, to borrow 
a phrase from the ethical theory of Immanuel Kant, “as an end” in himself/herself. 
Furthermore, any discussion of the issues under consideration would be incomplete if it 
did not repeatedly stress that it is the pride of the medical profession that the weak and 
defenseless, the powerless and unwanted, those whose grasp on the goods of life is fragile 
-- that is, real but reduced -- are cherished and protected as patients in greatest need.​21​ In 
this sense, justice is at the very heart of medicine’s vocation. 
3.3 Autonomy 
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 At its core, personal autonomy refers to “self-rule” that is free from interference 
and control by others and from certain limitations (such as inadequate understanding) that 
would deprive a person of the ability to make meaningful choices about his/her life. To 
respect autonomous agents is to acknowledge their right to hold views, to make choices, 
and to take actions based on their personal values and beliefs. Such respect involves 
respectful action,​ ​not merely respectful attitude.​ ​It requires more than noninterference in 
others’ personal affairs. It includes, in some contexts, building up or maintaining others’ 
capacities for autonomous choice while helping to allay fears and other conditions that 
destroy or disrupt autonomous action.​20  
Much like any rule, autonomy must be contextualized within a concrete set of 
circumstances. In other words, autonomy has limits. Respect for autonomy does not mean 
honoring another’s preference to do whatever he/she likes, regardless of the nature of the 
act in itself and its end, the relevant set of circumstances, the intentions of the moral 
agents involved, and the foreseen consequences.​20​ If personal morality comes down to 
nothing more than the exercise of free choice, with no principle available for moral 
judgment of the quality of those choices, then we will have, in the words of Daniel 
Callahan, a “moral vacuum.”​22 
In the context of a public health disaster, autonomy is sure to take on a new face. 
Restrictions on personal liberties are highly likely to ensue. The MDPH properly says 
that, in enacting any measure in which personal freedom is limited, the least restrictive, 
effective measure should be taken. Enactment of these measures should be based on the 
best available scientific evidence that:  
1. The liberty-limiting measure will achieve its intended goal. 
2. The limitation is proportional and no less restrictive measure is likely to be 
effective. An exception to this criterion may be justified if the less restrictive 
measure would be unduly burdensome (e.g., either too expensive or the agency 
responsible for implementation lacks the resources for expertise to implement). 
3. Failure to implement the measure is likely to result in grave harm to the 
functioning of society or to the well-being of the public. For example, if 
quarantine is enacted, then the duration of the quarantine should be clearly 
informed by transmission characteristics and should be as short as is medically 
justifiable. Home quarantine should be honored when reasonable and desired, and 
monitoring/surveillance should be as nonintrusive as is reasonable. We should 
continually be asking what justifies one further restrictive step. Restrictions on 
personal freedom should be equitably applied. It should be exceedingly clear why 
particular individuals or communities are being restricted and that the criteria that 
justify a restriction would be equitably applied to any and all individuals meeting 
the same criteria. Care must be taken to avoid stigmatization of individuals or 
groups. In addition, a process for questioning, appealing, and revising 
liberty-limiting measures should be in place and accessible when the level of 
urgency during a crisis makes this realistic.​18 
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 3.4 Human Dignity 
The essence of respect for human dignity is that each human being is invaluable. 
Human dignity makes clear that our incalculable worth as persons is not found in any 
usefulness granted us by others. We are not merely, in other words, of utilitarian value. 
As James Childress comments, one’s dignity as a person cannot be reduced to his or her 
past or future contribution to society.​23​ We are of worth, that is to say, by virtue of who 
we are, not as a result of what we do. That worth remains even when it is ignored by 
others. Every person, then, by virtue of dignity, has a right to respect and to ethical 
treatment. If justice is at the very heart of medicine’s vocation, then a thorough 
understanding of and respect for human dignity is its impetus and ultimate measure. 
3.5 First Come, First Served 
“First come, first served” is, of course, the traditional operative rule of clinical 
ethics. Patients are treated as they present themselves, and treatment continues as long as 
it is beneficial. This practice honors human dignity, because patients are treated 
according to their need, not their social worth or standing in any particular group. But can 
this principle be maintained in public health ethics when medical resources, such as 
ventilators, run short? Perhaps, but not necessarily. We have a model in the waitlist for 
organ transplants, where individuals are placed on the list in the order their need is 
identified. Exceptions to this rule, such as “jumping the queue,” have difficulty surviving 
ethical scrutiny. The CDC gave us another example during the flu vaccine shortage of 
2004, when it recommended “first come” for distribution after groups at high risk had 
been served.  
The immediate virtue of “first come” is that it is egalitarian: it is, in effect, a 
lottery in which everyone has an equal chance. It avoids invidious comparisons among 
people -- the ethical difficulties of favoring some over others. It is sometimes criticized as 
giving an unfair advantage to people who are well informed enough to present 
themselves first, leaving behind vulnerable groups. But if patients are admitted to the 
hospital by clinicians as they become seriously ill, and to the ICU as their need requires, 
the egalitarian lottery system works well enough. The incidence of illness is random and, 
in the sense that it does not favor some over others, fair. 
The most serious challenge to this rule or policy will come in the desire to remove 
certain patients from a full ICU to make room for others who are judged to be in greater 
medical need or more likely to benefit and/or survive. Should those who have arrived in 
the ICU by the egalitarian route of first come, first served, be subjected to a screening 
based on other grounds? We start with the medical screen: if it is judged that the patient 
cannot benefit from further intensive care, there is likely not an ethical problem in 
moving him/her to palliative care. But if the patient will benefit, and is nevertheless 
removed to make room for another with better prospects, this action must endure rigorous 
ethical justification in advance. (See Appendix A, nos. 3-4). 
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 3.6 Common Good 
The common good refers to the social conditions that allow people to reach their 
full potential and to realize their dignity. The common good implies that individual 
citizens and intermediate groups are obligated to make their specific contributions to the 
common welfare. Healthcare organizations are committed to serve the common good of 
society and should work to protect the well-being of its patients by: 
1. Protecting from discriminations those whose ability to pay or whose social 
condition places them in the margins of society. 
2. Enacting standards of care that work to the betterment of patients and service 
population. 
3. Using resource allocation -- including the scarce resource of one’s own health -- 
that does not arbitrarily disadvantage any particular patient group or community. 
4. Striving to ensure that burdens are not borne disproportionately by any patient, 
patient group, or community. 
5. Being concerned for the well-being of our clinicians and their family members, 
along with our patients and local communities. 
3.7 The Duty to Provide Care 
The duty to provide care is basic to the medical profession, inherent to its very 
nature. However, it is not an unlimited obligation. For instance, there is no duty to 
provide nonbeneficial care. In a situation of severe resource constraint, there may be no 
duty to provide full care for some if that means others will not receive even the most 
basic care. In other words, when rationing appears, the clinician must divide time and 
resources in such a way that is less than optimal for any given patient. Furthermore, in the 
case of COVID-19, we must also consider the problem of exposure to infectious diseases. 
Clinicians must inevitably consider the risk to their own health and thus the health of 
their families. This risk, which is accepted as a consequence of a freely-chosen 
profession, is a chief reason why they should receive priority in the distribution of 
preventives, such as vaccines. They bear a disproportionate burden in a pandemic in their 
efforts to protect and serve the public good, and so deserve the best measures available to 
guard their own health. There must also be sufficient measures in place to protect them 
legally in the extraordinary circumstances of disaster medicine. 
3.8 The Duty to Protect the Public from Harm 
A foundational principle of public health ethics is the obligation to protect the 
public from serious harm. This principle requires that citizens comply with imposed 
restrictions in order to ensure public wellbeing or safety. To protect the public from harm, 
Healthcare organizations may be required to restrict public access to service areas (e.g., 
restricted visiting hours), to limit availability of some services (e.g., elective surgeries), 
or to impose infectious control practices (e.g.,quarantine). When making decisions 
designed to protect the public from harm, decision makers should: 
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 1. Weigh the medical and moral imperative for compliance. 
2. Ensure stakeholders are made aware of the medical and moral reasons for public 
health measures. 
3. Ensure stakeholders are aware of the benefits of compliance and the consequences 
of noncompliance. 
4. Establish mechanisms to review these decisions as the public health situation 
changes and to address stakeholders concerns or complaints.​4 
3.9 Community Involvement  
Another concern is the need for community involvement and for transparency in 
the process of moral deliberation. We must work with one another and be inclusive of all 
populations, without distinction, in the effort to formulate a policy that works best for the 
society we inhabit together. The involvement of diverse voices in COVID-19 planning 
and in creating a transparent procedure for decision making is essential. A balance 
between centralized, federal control and state and local community implementation of 
central guidelines must be effectively struck. Moreover, healthcare organizations must 
adequately acknowledge and respond to any suspicion and distrust of the healthcare 
system. It is clear that public trust will be essential to ensure acceptance of, and 
compliance with, any necessary restrictive measures. To this end, healthcare 
organizations should include regional community leaders in the final review and 
implementation of these ethical guidelines. A procedure that maximizes transparency 
should include: 
1. Ensuring consistency in applying standards across people and time (treating like 
cases alike). 
2. Identifying decision makers who are impartial and neutral. 
3. Ensuring that those affected by the decisions have a voice in decision making and 
agree in advance to the proposed process. 
4. Treating those affected with dignity and respect. 
5. Ensuring that decisions are adequately reasoned and based on accurate 
information. 
6. Providing communication and processes that are clear, transparent, and without 
hidden agendas. 
7. Ensuring particular attention to historically marginalized and potentially 
vulnerable groups. 
8. Including processes to revise or correct approaches to address new information, 
including a process for appeals and procedures that are sustainable and 
enforceable.​18 
3.10 Other Criteria for Assigning Treatment Priority 
Some articles in the literature on scarce resource allocation introduce criteria that 
seem problematic. One is maximizing the years of life saved, not just the number of lives 
saved, and considering this an expression of the “greater good.” It suggests, in other 
words, that we prioritize those with the greatest number of years ahead of them, which 
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 favors long-term survival prospects and, inevitably, younger persons. Another is the 
life-cycle, or “fair innings,” argument, which suggests that we favor those who have not 
yet had the opportunity to live through life’s stages, which directly favors the young over 
the old.​19​ Still another is favoring those needed for the functioning of society.​18​ This 
would lead to endless argument about which roles are essential, would be hard to 
determine and apply fairly, would effectively marginalize those whose “social worth” is 
negligible, and would be counterproductive to public trust. 
Even after ethical guidelines have been spelled out, there will remain, of course, 
plenty of room for physician judgment and discretion, often very difficult and painful, in 
individual cases. A needed flexibility is required here, but it should be exercised within 
the policy guidelines insofar as it is possible. Ad hoc departures from the algorithm are 
ethically and legally unwise.​24​ It will also be prudent for triage decisions to be made and 
documented by a highly trained small group, rather than by an individual physician, 
because of the exceptional moral burden involved, entailing foreseeable adverse 
consequences for particular patients. We all recognize the pandemic as an exceptional 
situation that challenges our normal ethical wisdom and requires our best sensitivity and 
care for patients. 
4. RELEVANT ETHICAL VALUES 
Several ethical values bear on the realization of the theories and principles 
delineated above, and serve to inform clinical practice. 
 
4.1 Inclusiveness 
 
Decisions should be made explicitly with stakeholder views in mind and there 
should be opportunities for stakeholders to be engaged in the decision-making process. 
For example, decision-making related to staff deployment should include the input of 
affected staff.​4,25 
 
4.2 Openness and Transparency 
 
Decisions should be publicly defensible. This means that the process by which 
decisions were made will be open to scrutiny and the basis upon which decisions are 
made should be publicly accessible to affected stakeholders. For example, there should be 
a communication plan developed in advance to ensure that information can be effectively 
disseminated to affected stakeholders and that stakeholders know where to go for needed 
information.​4,25 
4.3 Reasonableness 
Decisions should be based on reasons (i.e., evidence, principles, values) that 
stakeholders can agree are relevant to meeting health needs in a pandemic COVID-19 
crisis, and they should be made by people who are credible and accountable. For 
example, triage decision makers should provide a templated rationale for prioritizing 
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 particular groups for medication and for limiting access to elective surgeries and other 
services.​4,25 
4.4 Responsiveness 
There should be opportunities to revisit and revise decisions as new information 
emerges throughout the crisis as well as mechanisms to address disputes and complaints. 
For example, if elective surgeries are cancelled or postponed, there should be a formal 
mechanism for stakeholders to voice any concerns they may have with the decision.​4,25 
4.5 Equity 
The principle of equity holds that, all things being equal, all patients have an 
equal claim to receive needed healthcare. During a COVID-19 pandemic, however, tough 
decisions should need to be made about which health services to maintain and which to 
defer due to extraordinary circumstances. Measures taken to contain the spread of a 
deadly disease will inevitably cause considerable collateral damage. In a COVID-19 
pandemic, this will extend beyond the cessation of elective surgeries and may limit the 
provision of emergent or necessary services, such as aggressive treatments for chronic 
obstructive pulmonary disease, heart failure, and end stage renal disease. At the same 
time, healthcare organizations are committed to ensuring that non-COVID-19 patients 
with readily treatable acute problems receive care. Decision makers should strive to:  
1. Preserve as much equity as possible between the interests of infected patients and 
those who need urgent treatment for other diseases.  
2. Ensure procedural fairness in decision-making.​4 
4.6 Privacy 
Individuals have a right to privacy in healthcare. In a public health crisis, it may 
be necessary to override this right to protect the public from serious harm. A 
proportionate response to the need for private information requires that it be released only 
if there are no less intrusive means to protect public health. Decision makers should:  
1. Disclose only private information that is relevant to achieve legitimate and 
necessary public health goals. 
2. Release private information only if there are no less intrusive means to protect 
public health. 
3. Determine whether the good that is intended is significant enough to justify the 
potential harm that can come from suspending privacy rights (e.g., the harm from 
stigmatization of individuals or particular communities). 
4. Provide public education to correct misconceptions about disease transmission 
and to offset misattribution of blame to particular communities.​4 
4.7 Proportionality 
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 Proportionality requires that restrictions to individual liberty and measures taken 
to protect the public from harm will not exceed what is necessary to address the actual 
level of risk to, or critical need of, the community. Decision makers should:  
1. Use the least restrictive or coercive measures in limiting or restricting liberties or 
entitlements. 
2. Use more coercive measures only in circumstances where less restrictive 
measures have failed to achieve appropriate public health ends.​4 
4.8 Reciprocity 
Reciprocity requires that society supports those who face a disproportionate 
burden in protecting the public good and takes steps to minimize the impact as far as 
possible. In pandemic COVID-19, measures to protect the public good are likely to 
impose a disproportionate burden on healthcare workers, patients, and their families. 
Clinicians may face expanded duties, increased workplace risks, physical and emotional 
stress, isolation from peers and family, and in some cases, infection leading to 
hospitalization or even death. Similarly, quarantined individuals or families of ill patients 
may experience significant social, economic, and emotional burdens. Decision makers 
are responsible for:  
1. Easing the burdens of healthcare workers, patients, and patient's families in their 
hospitals and in coordination with other healthcare organizations. 
2. Ensuring the safety of their workers, especially when redeploying staff in areas 
beyond the usual scope of practice.​4 
4.9 Solidarity 
COVID-19 has heightened the global awareness of the interdependence of health 
systems and the need for solidarity across systemic and institutional boundaries in 
stemming a serious contagious disease. Pandemic COVID-19 will not only require global 
solidarity, but also a vision of solidarity within and between healthcare institutions. 
Solidarity requires:  
1. Good, open, and honest communication. 
2. Open collaboration, in a spirit of common purpose, within and between healthcare 
institutions. 
3. Sharing public health information. 
4. Coordinating healthcare delivery, transfer of patients, and deployment of human 
and material resources.​4 
4.10 Stewardship 
In our society, both institutions and individuals will be entrusted with governance 
over scarce resources, such as vaccines, antivirals, ventilators, hospital beds, and even 
healthcare workers. During a COVID-19 outbreak, difficult decisions about how to 
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 allocate material and human resources will have to be made, and there will be collateral 
damage as a result of these allocation decisions. Those entrusted with governance roles 
should be guided by the notion of stewardship. Inherent in stewardship are the notions of 
trust, ethical behavior, and good decision making. Decision makers have a responsibility 
to:  
1. Avoid and/or reduce collateral damage that may result from resource allocation 
decisions. 
2. Maximize benefits when allocating resources. 
3. Protect and develop resources where possible. 
4. Consider good outcomes (i.e., benefits to the public good) and equity (i.e., fair 
distribution of benefits and burdens).​4 
4.11 Trust 
Trust is an essential component in the relationships between clinician and patient, 
between staff and the organization, between the public and healthcare providers, and 
between organizations within a health system. In a public health crisis, stakeholders may 
perceive public health measures as a betrayal of trust (e.g., when access to needed care is 
denied) or as abandonment at a time of greatest need. Decision makers will be confronted 
with the challenge of maintaining stakeholders’ trust while at the same time stemming a 
COVID-19 pandemic through various control measures. It takes time to build trust. 
Decision makers should:  
1. Take steps to build trust with stakeholders before the crisis hits locally.  
2. Ensure decision making processes are ethical and transparent to those affected 
stakeholders.​4 
CONCLUSION 
This white paper provides a basic framework of ethical considerations to guide 
decision makers at all levels in preparing for and responding to COVID-19, with 
specified attention to scarce resource allocation. As such, these guidelines are not 
narrowly prescriptive, but recognize the need of decision makers  to transform this 
guidance into specific decisions. Ethical decision making assumes that such judgments 
will be based on current scientific knowledge, that effectiveness of interventions is 
carefully assessed, and that transparency of the process is evident. As specific decisions 
are considered, processes should be in place for identifying which ethical issues were 
addressed, how guidelines were used, how decisions affected the community, and what 
lessons can be shared with other decision makers. In this way, these guidelines will 
continue to be an interactive, working document. 
REFERENCES 
 
1. Zoloth L, Zoloth S. Don't be chicken: bioethics and avian flu. The American Journal 
of Bioethics 2006, 6:5-8. 
13 
 2. Kotalik J. Addressing issues and questions relating to pandemic influenza planning: 
final report and recommendations. Health Canada; 2003. 
3. Tracy SC, Upshur R, Daar A. Avian influenza and pandemics. N Engl J Med 2005, 
352:1928. 
4. Thompson AK, Faith K,Gibson JL, and Upshur R. Pandemic influenza preparedness: 
an ethical framework to guide decision-making, BMC Medical Ethics 2006, 7(12): 
1-11. 
5. Bell J, Hyland S, DePelligrin T, Upshur R, Berstein M, Martin D. SARS and hospital 
priority setting: a qualitative case study and evaluation. BMC Health Services 
Research 2004, 4. 
6. Wynia MK, Gostin LO: Ethical challenges in preparing for bioterrorism: barriers 
within the healthcare system. American Journal of Public Health 
2004;97(7):1096-1102.  
7. Iserson KV, Pesik N. Ethical resources distribution after biological, chemical or 
radiological terrorism. Cambridge Quarterly of Healthcare Ethics 
2003;12(4):455-465. 
8. Pesik N, Keim ME, Iserson KV. Terrorism and the ethics of emergency medical care. 
Annals of Emergency Medicine. 2001;37(6):642-646.  
9. Veatch R. Disaster preparedness and triage: justice and the common good. The Mount 
Sinai Journal of Medicine, New York 2005;72(4):236-241.  
10. Kipnis K. Overwhelming casualties: medical ethics in a time of terror. Accountability 
in Research. 2003;10(1):57-68.  
11. Marer S, Sutjita M, Rajagopalan S. Bioterrorism, bioethics and the emergency 
physician. Topics in Emergency Medicine 2004;26(1):44-48. 
12. Center for Disease Control. Ethical Considerations for Decision Making Regarding 
Allocation of Mechanical Ventilators during a Severe Influenza Pandemic or Other 
Public Health Emergency. 2011;1-27. 
13. Daugherty-Biddison L, Gwon H, Regenberg A, Schoch-Spana M, Toner E. Maryland 
Framework for the Allocation of Scarce Life-sustaining Medical Resources in a 
Catastrophic Public Health Emergency. 2017;1-63. 
14. Italian Society for Anesthesia Analgesia Resuscitation and Intensive Care. Clinical 
ethics recommendations for admission to intensive care and for withdrawing 
treatment in exceptional conditions imbalance between needs and available resources. 
2020;1-5. 
15. Biddison EL, Faden R, Gwon HS, Mareiniss DP, Regenberg AC, Schoch-Spana M, 
Schwartz J, Toner ES. Too Many Patients...A Framework to Guide Statewide 
Allocation of Scarce Mechanical Ventilation During Disasters. Chest. 
2019;155(4):848-854. 
16. Veterans Health Administration. Meeting the challenge of pandemic influenza: 
Ethical guidelines for leaders and professionals in the Veterans Health 
Administration. 2010;1-71. 
17. Levin D, Cadigan RO, Biddinger PD, Condon S, Koh HK. Altered Standards of Care 
During an Influenza Pandemic: Identifying Ethical, Legal, and Practical Principles to 
Guide Decision Making. Disaster Medicine and Public Health Preparedness. 
2009;3(S2):S132-S140. 
14 
 18. Kinlaw K, Barrett DH, Levine RJ. Ethical Guidelines in Pandemic Influenza: 
Recommendations of the Ethics Subcommittee of the Advisory Committee of the 
Director, Centers for Disease Control and Prevention. Disaster Medicine and Public 
Health Preparedness. 2009;3(S2):S185-S192.  
19. White DB, Katz MH, Luce JM, Lo B.Who Should Receive Life Support During a 
Public Health Emergency? Using Ethical Principles to Improve Allocation Decisions. 
Annals of Internal Medicine. 2009; 150(2):132-138. 
20. Beauchamp TL, Childress JF. Principles of Biomedical Ethics, 6th ed. New York: 
Oxford University Press; 2009: 342.  
21. McCormick RA. To save or let die: The dilemma of modern medicine. JAMA. 1974 
Jul 8;229(2):172-6. 
22. McCormick RA. Bioethics: A Moral Vacuum?. America. 1999;180(15):8-12. 
23. Childress JF. Who Shall Live When Not All Can Live?. Soundings. 
1970;53(4):339-355. 
24. Devereaux AV, Dichter JR, Christian MD, et al. Definitive Care for the Critically Ill 
During a Disaster: A Framework for Allocation of Scarce Resources in Mass Critical 
Care: from a Task Force for Mass Critical Care Summit meeting, January 26-27, 
2007, Chicago, IL. Chest. 2008; 133(5): 63S.  
25. Daniels N. Accountability for reasonableness: Establishing a fair process for priority 
setting is easier than agreeing on principles.. BMJ: British Medical Journal. 
2000;321(7272):1300-1301. 
26. Troug RD, Mitchell C, Daly GQ. The toughest triage -- Allocating ventilators in a 
pandemic. ​NEJM​ 2020: 1-3. 
27. The Hastings Center. Ethical framework for health care institutions responding to 
novel coronavirus SARS-CoV-2 (COVID-19): Guidelines for institutional ethics 
services responding to COVID-19. 2020: 1-12. 
28. The Hastings Center. Responding to COVID-19: How to navigate a public health 
emergency legally and ethically. 2020. 
29. Washington Department of Public Health and Northwest Healthcare Response 
Network. Scarce resource triage team guidelines. 2020: 1-7. 
30. Houston Methodist Policy/Guidance on Crisis Standards of Care. 2020: 1-8. 
31. New York State Task Force on Life and Law. Ventilator allocation guidelines. 2015: 
1-272. 
32. Hick JL, Hanfling D, Wynia MK, Pavia AT. Duty to plan: Health care, crisis 
standards of care, and novel coronavirus SARS-CoV-2. Natl Acad Med 2020: 1-13. 
33. Rubinson L, Vaughn F, Nelson S, et al. Mechanical ventilators in US acute care 
hospitals. Disaster Med Public Health Preparedness 2010;4:199-206. 
34. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza 
A(H1N1) infection in Canada. JAMA. 2009;302:1872-1879. 
35. Dominguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 
influenza A(H1N1) in Mexico. JAMA. 2009;302:1880-1887. 
36. The Australia and New Zealand Extracorporeal membrane Oxygenation (ANZ 
ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 
influenza A(H1N1) acute respiratory distress syndrome. JAMA. 
2009;302:1888-1895. 
15 
 37. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza 
in Australia and New Zealand. N Engl J Med 2009;36:1925-1934. 
38. Arabi Y, Gomersall CD, Ahmed QA, Boynton BR, Memish ZA. The critically ill 
avian influenza A (H5N1) patient. Crit Care Med. 2007;35:1397–1403. 
39. Manocha S, Walley KR, Russell, JA. Severe acute respiratory distress syndrome 
(SARS): A critical care perspective. Crit Care Med. 2003;31:2684-2692. 
40. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute 
lung injury mortality: 1996-2005. Crit Care Med. 2009;37:1574-1579. 
41. Devereaux AV, Dichter JR, Christian MD, et al. Definitive care for the critically ill 
during a disaster: A framework for allocation of scarce resources in mass critical care. 
CHEST. 2008;133:151-66(S). 
42. Institute of Medicine. Guidance for Establishing Crisis Standards of Care for Use in 
Disaster Situations: A Letter Report. Washington DC: National Academy Press (US); 
2009. 
43. White DB, Katz MH, Luce JM, Lo B. Who should receive life support during a 
public health emergency? Using ethical principles to improve allocation decisions. 
Ann Intern Med. 2009;150:132-138. 
44. Burkle FM, Jr. Mass casualty management of a large-scale bioterrorist event: An 
epidemiological approach that shapes triage decisions. Emergency Medicine Clinics. 
2002;20:409-436. 
45. Powell T, Christ KC, Birkhead GS. Allocation of ventilators in a public health 
disaster. Disaster Med Public Health Prep. 2008;2:20-26. 
46. Gostin LO. Public Health Law: Power, Duty, Restraint. 2nd ed. Berkeley: University 
of California Press; 2008, pp 421-458. 
47. The Keystone Center. Citizen Voices on Pandemic Flu Choices. A Report of the 
Public Engagement Pilot Project on Pandemic Influenza. 2005.  
48. The Keystone Center. The Public Engagement Project on Community Control 
Measures for Pandemic Influenza: Findings and Recommendations from Citizen and 
Stakeholder Deliberation Days; 2007.  
49. Ohio State University, Center for Public Health Practice. Ohio Pandemic influenza 
public engagement demonstration project: Mass fatality management, Final 
Report;2009. 
50. Public Health-Seattle & King County. Public engagement project on medical service 
prioritization during an influenza pandemic. Seattle, WA: Health care decisions in 
disasters; 2009. 
51. Vawter DE, Garrett JE, Gervais KG, et al. For the good of us all: Ethically rationing 
health resources in Minnesota in a severe influenza pandemic. Minneapolis, MN: 
Minnesota Center for Health Care Ethics and University of Minnesota Center for 
Bioethics; 2010. 
52. Pesik N, Keim ME, Iserson KV. Terrorism and the ethics of emergency medical care. 
Annals of emergency medicine. 2001;37(6):642-646. 
53. Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for 
critical care during an influenza pandemic. CMAJ. 2006;175(11):1377-1381 
16 
 54. Childress JF (Ed). Triage in Response to a Bioterrorist Attack. In: Moreno J, ed. In 
the wake of terror: Medicine and morality in a time of crisis. Cambridge, MA: The 
MIT Press; 2003:77-93. 
55. NYS Workgroup on Ventilator Allocation in an Influenza Pandemic, NYS DOH/ 
NYS Task Force on Life & the Law. NYS document Allocation of Ventilators in an 
Influenza Pandemic: Planning Document; 2007.  
56. Utah Hospitals and Health Systems Association Triage Guidelines Workgroup. Utah 
pandemic influenza hospital and ICU triage guidelines.2009.  
57. Minnesota Department of Health. Mechanical ventilation strategies for scarce 
resource situations; 2010.  
58. Hick JL, O'Laughlin DT. Concept of operations for triage of mechanical ventilation 
in an epidemic. Academic Emergency Medicine. 2006;13:223-229. 
59. Daniels N. Fair process in patient selection for antiretroviral treatment in WHO's goal 
of 3 by 5. The Lancet. 2005;366(9480):169-171. 
60. Shortt SE. Waiting for medical care: Is it who you know that counts? CMAJ. 
1999;161:823-824. 
61. Sanders D, Dukeminier J. Medical advance and legal lag: Hemodialysis and kidney 
transplantation. UCLA Law Review. 1968;15:366-380. 
62. Rescher N. The allocation of exotic medical lifesaving therapy. Ethics. 
1969;79(3):173-186. 
63. Ramsey PG. Patient as Person. New Haven, CT: Yale University Press; 1970. 
64. Department of Health and Human Services. HHS Pandemic Influenza Plan; 2005. 
65. Department of Health and Human Service. Guidance on Allocating and Targeting 
Pandemic Influenza Vaccine; 2008.  
66. Gostin LO, Sapsin JW, Teret SP, et al. The model state emergency health powers act: 
Planning for and response to bioterrorism and naturally occurring infectious diseases. 
JAMA. 2002;288:622-628 
67. Emanuel EJ, Wertheimer A. Public health. Who should get influenza vaccine when 
not all can? Science. 2006;312:854-855. 
68. Williams A. Intergenerational equity: An exploration of the 'fair innings' argument. 
Health Econ. 1997;6:117-132. 
69. Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for 
allocation of donor liver grafts: Survey of public and clinicians. BMJ. 
1998;317:172-175. 
70. Harris J. The Value of Life. London: Routledge & Kegan Paul; 1985. 
71. Brock DW. Ethical issues in recipient selection for organ transplantation, In Mathieu 
D (Ed). Organ Substitution Technology: Ethical, Legal, and Public Policy Issues. 
London: Westview Press; 1988. 
72. Kamm FM. Morality/Mortality. Volume One. Death and Whom to Save From It. 
Oxford: Oxford University Press; 1993. 
73. Daniels N. Rationing fairly: Programmatic considerations. Bioethics. 
1993;7:224-233. 
74. Daniels N, Sabin J. Limits to health care: Fair procedures, democratic deliberation, 
and the legitimacy problem for insurers. Philosophy & Public Affairs. 
1997;26(4):303-350. 
17 
 75. Tanner L. Who should MDs let die in a pandemic? Report offers answers. 
Washington Post. May 5, 2008. 
76. Lo B, White DB. Intensive care unit triage during an influenza pandemic: The need 
for specific clinical guidelines. In Lemon SM, Hamburg MA, Sparling F, Choffnes 
ER, Mack A (Eds). Ethical and Legal Considerations in Mitigating Pandemic 
Disease. Washington, D.C.: National Academies Press; 2007:192-197. 
77. Curtis JR, Rubenfeld GD, eds. Managing Death in the ICU: The Transition from Cure 
to Comfort. New York: Oxford University Press; 2000. 
78. Lo B, Rubenfeld G. Palliative sedation in dying patients: "We turn to it when 
everything else hasn't worked." JAMA. 2005;294(14):1810-1816. 
79. Okie S. Dr. Pou and the hurricane: Implications for patient care during disasters. New 
England Journal of Medicine. 2008;358(1):1-5. 
80. Quill TE, Lo B, Brock DW, Meisel A. Last-resort options for palliative sedation. 
Annals of Internal Medicine. 2009;151(6), 421-424. 
81. Lo B. Resolving Ethical Dilemmas: A Guide for Clinicians. 4th ed. Philadelphia: 
Lippincott Williams & Wilkins; 2009. 
82. President's Commission for the Study of Ethical Problems in Medicine and 
Biomedical and Behavioral Research: Deciding to Forego Life-Sustaining Treatment. 
Washington, DC: US Government Printing Office; 1983. 
83. Luce JM, Alpers A. Legal aspects of withholding and withdrawing life support from 
critically ill patients in the United States and providing palliative care to them. 
American journal of respiratory and critical care medicine.. 2000;162:2029-2032. 
84. Meisel A. The Right to Die. 2nd ed. New York: John Wiley & Sons; 1995. 
85. American Thoracic Society Bioethics Task Force. Withholding and withdrawing life- 
sustaining therapy. Am Rev Respir Dis. 1991;144:726-731. 
86. Truog RD, Campbell ML, Curtis JR, et al. Recommendations for end-of-life care in 
the intensive care unit: a consensus statement by the American College of Critical 
Care Medicine. Critical Care Medicine.2008;36:953-963. 
87. White DB, Curtis JR, Wolf LE, et al. Life support for patients without a surrogate 
decision maker: Who decides? Ann Intern Med. 2007;147:34-40. 
88. White DB, Curtis JR, Lo B, Luce JM. Decisions to limit life-sustaining treatment for 
critically ill patients who lack both decision-making capacity and surrogate decision- 
makers.  Critical Care Medicine. 2006;34:2053-2059. 
89. Ward NS, Teno JM, Curtis JR, Rubenfeld GD, Levy MM. Perceptions of cost 
constraints, resource limitations, and rationing in United States intensive care units: 
Results of a national survey.  Critical Care Medicine. 2008;36:471-476. 
90. National Commission on Children and Disaster. 2010 Report to the President and 
Congress. AHRQ Publication No. 10-M037. Rockville, MD: Agency for Healthcare 
Research and Quality; 2010.  
91. Kissoon N. Task Force for Pediatric Emergency Mass Critical Care Task Force. 
Deliberations and recommendations of the Pediatric Emergency Mass Critical Care 
Task Force: executive summary. Pediatr Crit Care Med. 2011;12(6 suppl):S103-108. 
92. Centers for Disease Control and Prevention. Coordinating pediatric medical care 
during an influenza pandemic: Hospital workbook. Prepared by Oak Ridge Institute 
for Science and Education;2010.  
18 
 93. Stohr K: Avian influenza and pandemics: research needs and opportunities. New 
England Journal of Medicine. 2005;352(4):405-407.  
94. Osterholm MT: Preparing for the next pandemic. New England Journal of 
Medicine.2005;352:1839-1842. 
95. Tam T, Sciberras J, Mullington B, King A: Fortune favours the prepared mind: a 
national perspective on pandemic preparedness. Canadian Journal of Public Health. 
2005;96:406-408.  
96. Reichert TA: Preparing for the next influenza pandemic. The Pediatric Infectious 
Disease Journal. 2005;24:S228-S231.  
97. Wong S, Yuen K: Avian influenza virus infections in humans. Chest. 
2006;129:156-168.  
98. Beauchamp E, Steinbock B: New Ethics for the Public's Health. New York, Oxford 
University Press; 1999.  
99. Callahan D, Jennings B: Ethics and public health: forging a strong relationship. 
American Journal of Public Health. 2002;92:169-176.  
100. Kotalik J: Preparing for an influenza pandemic: ethical issues. Bioethics. 
2005;19:422-431.  
101. Perhac R: Comparative risk assessment: where does the public fit in? Science, 
Technology and Human Values 1998;23:221-241.  
102. MOHLTC: Ontario Health Pandemic Influenza Plan. Toronto. 2005.  
103. Upshur R: Principles for the justification of public health intervention. Can J 
Public Health. 2002;93:101-103.  
104. Gostin LO: Public health, ethics, and human rights: a tribute to the late Johnathan 
Mann. J Law Med Ethics. 2001;29:121-130.  
105. O'Neill O: Public Health or Clinical Ethics: Thinking beyond Borders. Ethics & 
International Affairs. 2002;16. 
106. Wynia MK, Gostin LO: Ethical challenges in preparing for bioterrorism: barriers 
within the healthcare system. Am J Public Health. 2004;97(7):1096-1102. 
 
 
 
 
 
 
 
 
 
 
 
The remainder of this page is intentionally left blank.  
19 
 APPENDIX A: ADDRESSING SPECIFIC ETHICAL QUESTIONS  
THAT MAY ARISE IN CLINICAL PRACTICE  
1. What is the Utah Model referenced in Section 1? What role should it play for 
ethical decision making in the context of COVID-19? 
The guidance in the Utah Model gives priority to patients for whom 
treatment would most likely be lifesaving and whose functional outcome would most 
likely improve with treatment.​ This priority is given over those who would likely die 
even with treatment and those who would likely survive without treatment. It utilizes a 
list of specific diseases and conditions that would exclude patients from admission to a 
hospital based on the reduced survivability of their disease or condition as well as the 
disproportionate amount of healthcare services and resources necessary to care for them. 
Care for these patients would be palliative versus curative. The model utilizes a similar 
set of criteria to evaluate patient admission to an ICU​. The disease/condition criteria 
should be used by an independent, peer-based, scarce resource allocation triage 
team of senior clinicians and organizational leaders with experience in tertiary 
triage (e.g., Critical Care, Emergency Medicine, Trauma Surgery, etc.), clinical 
ethics, palliative care, nursing, spiritual services, risk management, etc., with one 
designated as Chair who oversees all oversight processes.​ This triage team provides 
ongoing evaluation of patients for hospital admission, intensive care admission, and 
termination of life-sustaining treatment. 
2. What is the independent, peer-based, scarce resource allocation triage team based 
on? How should healthcare organizations use it to formulate its allocation 
decisions?  
There are several models that support independence from the case in making 
scarce resource allocation decisions, but ​the model developed by the New York State 
Task Force on Life and Law​, which is recommended by the Massachusetts Hospital 
Association, seems especially strong. In the New York model, ​the creation of a scarce 
resource allocation committee that is completely separate from the treating clinician 
allows the decision about who receives a scarce resource to be based on a review of 
objective data. By removing the decision entirely from the treating clinician, severe 
emotional distress may be mitigated. 
Understandably, clinicians will, in general, attempt to interpret priority rules in a 
way that favors the access of their own patients to scarce life-sustaining therapies, such as 
organ transplants and placement in the ICU for ventilator therapy. ​It is very helpful, in 
the interest of fair distribution of such therapies, to have well-formulated 
prioritization guidelines that are interpreted (in particular cases) by professionals 
who have no fiduciary commitment to the individual patient. 
Separating the roles of clinical care and triage allows clinicians who are caring for 
patients with respiratory failure secondary to COVID-19 infection to continue to maintain 
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 loyalty to their patients and to act in their best interests. ​This separation of roles will 
mean that treating clinicians will not need to make a decision to withhold 
mechanical ventilation from patients who still desire it. ​Instead, a scarce resource 
allocation committee will make decisions impartially based on the overall outcomes for 
the population according to predetermined guidelines, while the treating clinician is free 
to act in the best interests of the individual patient, within the constraints of the public 
health emergency. Constant communication with the treating clinician and establishment 
of prioritization of patients to receive a critical resource is necessary in the event that 
scarce resources become available. 
3. Should clinicians receive priority for scarce resource allocation? 
There are long-standing ethical justifications for prioritizing the distribution 
of scarce resources to clinicians on the front lines, who serve as the very basis for 
our ability to provide care for the larger patient population.​ Without able clinicians, 
healthcare organizations are unable to provide needed healthcare to the general 
population. For that reason, grounded in the principle of utility, clinicians on the front 
lines should be prioritized in scarce resource allocation protocols. 
4. What is the role of ECMO in COVID-19 preparedness? How should healthcare 
organizations decide who will receive ECMO? 
The role of ECMO in the management of COVID-19 is unclear at this point. It 
has been used in some patients with COVID-19 in China, but detailed information is 
unavailable. ECMO may have a role in the management of some patients with 
COVID-19 who have refractory hypoxemic respiratory failure. However, much about the 
virus is unknown, including the natural history, incidence of late complications, viral 
persistence, or the prognoses in different subsets of patients. This uncertainty might be 
compared to the emergence of influenza A (H1N1) in 2009, when it was initially unclear 
what the role of ECMO should be. 
That being said, ​healthcare organizations should follow their policy on ECMO 
procedures to determine the candidacy of the patient ​with COVID-19 for ECMO 
therapy by employing a national, peer-reviewed scoring standard. 
5. What should healthcare organizations do if multiple patients have similar ECMO 
scores? In other words, who will receive ECMO therapy in the event that not all 
can? 
This should be determined after careful and critical analysis by a team of relevant 
experts (see 1A above). To aid in the process of these determinations, ​supplemental 
metrics (i.e., scoring systems) should be introduced ​that take into consideration the 
following. 
● Likelihood of​ long-term net clinical ​benefit​. 
● Quality-adjusted ​life years​ (QALY). 
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 ● Urgency​ of need. 
● Duration​ of benefit. 
● Long-term ​quality​ ​of life. 
● Availability of resources​ required to secure long-term benefit. 
 
6. How should healthcare organizations distribute scarce resources other than 
ventilators, oscillators, and ECMO in the context of COVID-19? 
Heeding the advice of the American Medical Association Code of Ethics, 
decisions regarding the allocation of limited medical resources among patients, 
healthcare organizations should consider only ethically appropriate criteria relating to 
medical need. These criteria include, but are not limited to, likelihood of benefit, urgency 
of need, change in quality of life, duration of benefit, and, in some cases, the amount of 
resources required for successful treatment.  
In general, only very substantial differences among patients are ethically relevant; 
the greater the disparities, the more justified the use of these criteria becomes. In making 
quality of life judgments, patients should first be prioritized so that death or extremely 
poor outcomes are avoided; then, patients should be prioritized according to change in 
quality of life, but only when there are very substantial differences among patients.  
Non-medical criteria, such as ability to pay, social worth, patient 
contribution to illness, or past use of resources should not be considered.​ Allocation 
decisions should respect the individuality of patients and the particulars of individual 
cases as much as possible. When very substantial differences do not exist among 
potential recipients of treatment on the basis of the appropriate criteria defined above, a 
“first come, first served” approach or some other equal opportunity mechanism should be 
employed to make final allocation decisions.  
Though there are several ethically acceptable strategies for implementing these 
criteria, no single strategy is ethically mandated. Acceptable approaches include a 
three-tiered system, a minimal threshold approach, and a weighted formula. 
Decision-making mechanisms  should be objective, flexible, and consistent to ensure 
that all patients are treated equally.​ ​Treating clinicians must remain patient 
advocates, and therefore should not make allocation decisions.  
Patients denied access to resources have the right to be informed of the reasoning 
behind the decision. 
Patients who are currently receiving life-sustaining medical treatments, such 
as mechanical ventilation, that are conferring net clinical benefit should not 
necessarily see an adjustment in their care. ​However, patients or surrogates who freely 
and with full consent initiate a conversation with the healthcare team about their desire to 
limit or withdraw life-sustaining medical treatment so that it can be allocated elsewhere 
should have this wish considered and, where appropriate, honored. Advance directive 
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 documents should be evaluated and acknowledged by the healthcare team for the patient 
affected by severe chronic illnesses. 
7. How should healthcare organizations treat non-COVID-19 patients who need, but 
are not yet receiving, life-sustaining medical treatments, such as mechanical 
ventilation? 
Upon initiation of scarce resource allocation protocol, all decisions​ regarding 
life-sustaining medical treatment, such as mechanical ventilation, ​should be subject to 
the clinical scoring system, such as that delineated in the Utah Model. This should 
be applied unilaterally to all patients, regardless of COVID-19 status. 
8. How should healthcare organizations treat COVID-19 and non-COVID-19 patients 
who are not, for whatever reason, candidates for life-sustaining medical treatments, 
such as mechanical ventilation? 
Patients who are not​, for whatever reason, ​candidates for life-sustaining 
treatment​, such as mechanical ventilation, ​should receive respectful and 
compassionate palliative care to relieve their symptoms. ​If conventional palliative 
interventions fail to relieve symptoms, ​adjusted doses of sedatives and analgesics that 
will cause unconsciousness may become appropriate.​ In this case, healthcare 
organizations should follow the protocol of relevant policies on palliative sedation 
therapy. Although palliative sedation therapy has strong ethical and legal justification, 
clinicians are often confused about the distinction between palliative sedation, which is 
intended to relieve suffering, and active euthanasia, which is intended to cause death. 
During a public health emergency, such misunderstandings may be particularly 
prominent. Thus, our emergency-preparedness plan includes training and educational 
resources for clinicians about palliative sedation, for providing emotional and spiritual 
support to patients and families, and for addressing medication and staffing shortages. 
9. How should healthcare organizations communicate triage decisions to patients and 
families of patients who are not, for whatever reason, candidates for life-sustaining 
medical treatments, such as mechanical ventilation? 
Healthcare organizations should employ the following guidelines developed by 
the Center to Advance Palliative Care on COVID-ready communication skills. (Please 
note that these can be modified by individual clinicians, as necessary.) 
Table 1. Covid-Ready Communication Skills (Adapted from the Center to Advance 
Palliative Care) 
What they say 
 
What you say 
Why can’t my 90 year old 
grandmother go to the ICU? 
 
This is an extraordinary time. We are trying to use resources in 
a way that is fair for everyone.​ Your grandmother’s situation 
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 does not meet the criteria for the ICU today. I wish things were 
different.  
 
Shouldn’t I be in an 
intensive care unit? 
 
Your situation does not meet criteria for the ICU right now. The 
hospital is using special rules about the ICU because we are 
trying to use our resources in a way that is fair for everyone. ​If 
this were a year ago, we might be making a different decision. 
This is an extraordinary time. ​I wish I had more resources. 
 
My grandmother needs the 
ICU! Or she is going to die! 
I know this is a scary situation, and I am worried for your 
grandmother myself. ​This virus is so deadly that even if we 
could transfer her to the ICU, I am not sure she would make it. 
So we need to be prepared that she could die. We will do 
everything we can for her. 
 
Are you just discriminating 
against her because she is 
old? 
No. ​We are using guidelines that were developed by people in 
this community to prepare for an event like this​ -- clinicians, 
policymakers, and regular people -- ​so that no one is singled 
out​. These guidelines have been developed over the course of 
years. I know it is hard to hear this.  
 
You’re treating us 
differently because of the 
color of our skin. 
 
I can imagine that you may have had negative experiences in 
the past with healthcare simply because of who you are.​ That is 
not fair, and I wish things had been different. The situation today 
is that our medical resources are stretched so thin that we are 
using objective guidelines so that we can be fair. 
 
It sounds like you are 
rationing. 
What we are doing is trying to spread out our resources in the 
best way possible. ​This is a time where I wish we had more for 
every single person in this hospital. 
 
You’re playing God. You 
can’t do that.  
 
I am sorry. I did not mean to give you that feeling. I am just a 
clinician doing the best I can. ​Across the country, every hospital 
is working together to try to use resources in a way that is fair 
for everyone. I realize that we don’t have enough.​ I wish we 
had more. Please understand that we are all working as hard as 
possible. Let me connect you with one of our chaplains. 
How could you withhold 
treatment from my child? 
You are letting my child 
die! 
It is painful for me to say that your child does not meet 
criteria right now based on his/her life-limiting illness. 
You have done everything you can to take care of your 
child. This is a terrible situation, and we are forced to 
make decisions that are very different from the way we 
normally practice medicine. We are making these hard 
decisions for adult patients and for other children, too. We 
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 feel this loss with you and are here to support you. I wish I 
had more options to offer your child.  
 
10. Who should communicate healthcare organization’s triage decisions to patients 
and families of patients who are not, for whatever reason, candidates for 
life-sustaining medical treatments, such as mechanical ventilation? 
A member of the Scarce Resource Allocation Triage Team, a Triage Officer, the 
hospital Chief Medical Officer (CMO), or a combination thereof should communicate 
triage decisions to patients and families of patients who are not, for whatever reason, 
candidates for life-sustaining medical treatments, such as mechanical ventilation. (See 
Appendix B, no. 2.) 
11. How should healthcare organizations determine decisions regarding 
cardiopulmonary resuscitation (CPR)? 
Consistent with current policies on non-beneficial and/or harmful treatments, an 
attending physician is not obligated to offer or to provide CPR if resuscitative treatment 
would be medically inappropriate, even at the request of a patient or legally authorized 
representative. For patients with COVID-19, a determination that CPR would be 
medically inappropriate may be made on the grounds that CPR would not serve a medical 
purpose because of the patient’s prognosis with or without CPR. In addition, for patients 
infected with COVID-19, the risks to clinicians of performing CPR may influence a 
determination that CPR is not medically appropriate, if coupled with considerations of 
that patient’s prognosis. 
In the event that healthcare organizations implement their Scarce Resource 
Allocation Protocol, it may also be appropriate not to offer CPR for certain patients with 
or without COVID-19, on the grounds that if the patient had a cardiac arrest and return of 
spontaneous circulation were achieved, the patient would not receive a high enough 
priority for subsequent critical care. When possible, this determination should be made in 
coordination with the relevant Triage Officer.  
 If an attending physician, in conjunction with other clinicians involved in a 
patient’s care, determines that CPR is not medically appropriate for any of the above 
reasons, he or she should solicit the independent review of a second attending physician 
who is not involved in the patient’s care. If the second attending concurs that CPR is 
medically inappropriate, then a Do Not Resuscitate order should be entered, and the 
primary attending should document in the electronic health record how the decision was 
made. 
 Physicians who decide not to offer CPR should inform the patient or 
representative of this decision and its rationale, and assure the patient that he or she will 
continue to receive all other forms of indicated care. The consent of the patient or 
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 representative will be sought, but it is not required. The Scarce Resource Allocation 
Triage Team should be notified in the event that an objection arises. 
12. How should healthcare organizations determine the best use of severely limited 
equipment, such as personal protective equipment (PPE)? Should clinicians be 
asked to work without adequate PPE? 
Generally, ​clinicians have a duty to provide potentially life-saving treatments 
to patients unless it is impossible to adequately mitigate risk to self or others. ​Codes 
of ethics for all clinicians include a duty to provide care for patients even at some risk to 
self. This is a primary ethical duty of the healthcare professional, but it is not absolute, 
and there are ethically justifiable exceptions. Those ​exceptions occur when there is 
disproportionate risk to the clinicians providing the care. 
In considering risks related to providing treatment to a patient with COVID-19 
who endures, for instance, cardiopulmonary arrest, we begin with the ethical assumption 
that patients are entitled to clinically indicated care for which they have provided 
informed consent. The determination of disproportionate risk must be based on the best 
available evidence about the treatment of patients with COVID-19. At the time of this 
writing, the CDC has provided interim guidance for risk assessment of healthcare 
personnel with potential exposures to patients with COVID-19.  
The CDC considers it a medium-risk exposure when clinicians who are 
wearing appropriate PPE have exposure to procedures that generate aerosols or 
during which respiratory secretions are likely to be poorly controlled​ (e.g., CPR, 
intubation, extubation, bronchoscopy, nebulizer therapy, sputum induction) on patients 
with COVID-19.  
Based on the best available evidence, decision makers should weigh the potential 
benefit of CPR to the patient with the risk that the treatment poses to the clinicians 
providing it. ​Treatment should only be limited when the risks to clinicians are far 
greater than the potential benefits that the treatment is expected to offer the patient. 
Even in an emergency situation, such as a cardiopulmonary arrest,​ clinicians should 
never compromise safety protocols ​because doing so results in more overall harm than 
benefit given the high risk of infection without PPE. ​Clinicians should always don 
appropriate PPE before performing a code for a patient with COVID-19, even if it 
means delaying the code. 
The ethical principle of veracity supports informing patients and/or surrogates that 
in the event of a cardiopulmonary arrest, there may be a delay in responding while the 
code team or other first-responders don the required PPE. However, ​neither patients nor 
surrogates have the right to request that any clinician administer CPR without PPE 
as this would expose others to disproportionate risk.  
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 APPENDIX B: TRIAGE AND SCARCE RESOURCE ALLOCATION  
QUICK GUIDE 
1. Scarce Resource Allocation Triage Initiation 
In the event of scarce resource allocation triage initiation , Incident Command 
personnel should send daily reports on COVID-19 cases to all critical care and 
emergency department directors. This group should coordinate with the hospital CMO to 
place patients on relevant units to meet needs for critical care. 
 If strategies to increase hospital capacity and optimize patient distribution are 
insufficient to meet the healthcare needs of patients, triage of critical care resources is 
ethically appropriate.  
2. Scarce Resource Allocation Triage Process 
The Scarce Resource Allocation Triage Team (SRATT) should be comprised of 
senior clinicians and organizational leaders with experience in tertiary triage (e.g., critical 
care, emergency medicine, trauma surgery, etc.), clinical ethics, palliative care, nursing, 
spiritual services, risk management, etc., with one designated as Chair who oversees all 
oversight processes. 
The SRATT should convene regularly when the scarce resource allocation 
protocol (SRAP) is being implemented. Activities of the SRATT should include: 
● Making recommendations about triage decisions if requested by the Triage 
Officers. 
● Handling requests for re-evaluation of assigned priority scores​. Triage decisions 
will be upheld or overturned based on the SRATT’s evaluation of whether the 
SRAP was appropriately followed. 
●  Reviewing triage decisions for appropriateness and consistency. 
● Updating the SRAP when necessary. 
The relevant chiefs of the pediatric and adult ICUs, as well as the pediatric and 
adult emergency departments, should serve as Triage Officers (TOs). TOs (or designees) 
should work with the hospital CMO to​ ​apply the SRAP and make determinations 
regarding critical care treatment for all affected patients. To the extent possible, TOs (or 
designees) should not be involved in both triage and patient care simultaneously. 
Triage decisions should be made in accordance with the SRAP and applied 
consistently and objectively to all patients.  Appropriate technology should be used to 
augment clinical assessment. Technology to be used has to be non-complex, accessible, 
and designed for maximal impact with minimal need for transport or breach of infection 
control measures and easy to maintain. 
Triage decisions for each patient should be reassessed at least every 24 hours. 
The degree of scarce resource allocation through triage is determined by the 
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 supply-demand imbalance and should be proportionate to the expected shortfall in 
resources.  
3. Scarce Resource Allocation Protocol (SRAP) 
The SRAP is based on the best available scientific evidence and is consistent with 
the following ethical guidelines: 
● Triage decisions should be made primarily on the likelihood of net clinical benefit 
as determined by expected incremental increase in short-term and long-term 
survival. Patients most likely to survive to discharge from the hospital and to live 
longest in the community after discharge are given priority. 
● Triage decisions may also take into account patients’ anticipated quality of life 
and the resources required to achieve incremental survival. Patients who are 
expected to survive with minimal quality of life or who will require a 
disproportionate amount of resources to survive are given lower priority. 
● If patients have similar expected incremental increases in survival, priority should 
be given to those whose quality-adjusted life years are greater in number. 
● Patients should be triaged according to this protocol regardless of the cause of 
their need for critical care, ability to pay, or role in the community. 
When the SRAP is active, patients should be eligible for critical care according to 
the inclusion and exclusion criteria described in the Utah Model. This scoring system for 
assessing expected incremental increase in survival should be used to support clinical 
judgment in making triage decisions. 
In the absence of an exact, evidence-based scoring system for likelihood of 
COVID-19 survival, the Sequential Organ-Failure Assessment (SOFA/pSOFA) scoring 
system (or similar) should be used to determine patient severity of illness and expected 
mortality. 
Additionally, clinicians may use a known scoring system (such as the PRISM III 
or APACHE II) to aid in assessment. 
Patients who are not, for whatever reason, candidates for life-sustaining 
treatments should be provided adequate comfort care and symptom management. Patients 
receiving comfort care should not be admitted to the ICU, and palliative care clinicians 
(or, where reasonable, staff trained in comfort care) should direct the care of such 
patients, if feasible.  
It is clinically inappropriate to attempt cardiopulmonary resuscitation (CPR) or 
intubation on patients who have not been offered concurrent life-sustaining medical 
treatment. 
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 If a clinician has appealed the Triage Officers’ decision not to offer critical care, 
that patient should receive comfort care on a time-limited basis until the appeal has been 
reviewed by the SCATT. 
 
 
 
 
 
 
 
The remainder of this page is intentionally left blank.  
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 APPENDIX C: SCARCE RESOURCE ALLOCATION TRIAGE TEAM  
QUICK GUIDE 
1. Purpose 
History indicates that there are times when demand for healthcare exceeds the 
ability of health systems to supply it.​1​ In such circumstances, “triage standards of care” 
are ethically justified to allocate healthcare resources according to broadly 
consequentialist reasoning, meaning that a shift from focusing on the individual 
autonomy of patients to the overall public good is warranted.​2 
The novel COVID-19 pandemic​3​ has caused sufficient crises in other countries​4​ to 
indicate that it may impact the U.S. healthcare system such that in some localities a shift 
from normal standard of care to a triage standard of care may be necessary. 
A Scarce Resource Allocation Triage Team (SRATT) should therefore be created 
for the purpose of developing and implementing ethical methods for allocating scarce 
healthcare resources and supporting healthcare professionals in a crisis circumstance. 
 
2. SRATT Operations Procedures 
 The SRATT should be a subcommittee of the COVID-19 Clinical Planning and 
Education Workgroup, with direct relationships to Incident Command. The SRATT has 
two basic functions: 
1. To develop guidance for ethically allocating scarce healthcare resources and 
supporting healthcare professionals in a crisis circumstance. 
2. To implement allocation methods, making choices to provide, withhold, or 
withdraw scarce resources from patients in a crisis. 
When developing guidance and supporting healthcare professionals,​ the SRATT 
requires a quorum to operate, defined as one third of all primary or secondary 
members​, as described below. (​Allowance will be made to replace SRATT members if 
needed in the event of illness or to maintain a quorum.)​ In this function, which is 
anticipated to occur prior to (and potentially during) implementing triage standards of 
care, the SRATT meets regularly to work on developing and agreeing upon the ethical 
framework for decision making, clinical algorithms for triage, educational materials and 
methods, and other business as needs arise. All SRATT business of this nature may be 
performed remotely, including any voting required to ratify committee actions. 
When making allocation decisions, the SRATT operates in smaller groups, 
called decision making teams (DMTs) of at least two individuals, preferably three, 
one of whom must always be a physician.​ As long as circumstances allow it, preference 
should be to staff SRATT-DMTs solely by physicians. 
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 Allocation decisions are decisions to provide or withhold a resource (e.g., a 
hospital bed, ventilator, etc.) to or from a patient when resources are scarce, meaning that 
the volume of patients in need of the resource is far greater than the amount of the 
resource available. ​Allocation decisions are made by the SRATT, in smaller groups, 
using guidelines endorsed by the SRATT and approved institutionally, not by 
individual healthcare professionals at the bedside. ​In this way, frontline healthcare 
providers are spared the moral burden of having to make allocation decisions. 
In the event the hospital anticipates a surge of patients to such an extent that triage 
standards of care are likely to be implemented and allocation decisions likely to be 
necessary, the SRATT Chair (hospital CMO or designee) should designate one or more 
members of the SRATT to: 
● Group members into sets of three to form decision making teams (DMTs). 
● Coordinate an on-call schedule for DMTs, such that they are available 24 hours a 
day, 7 days a week. 
● Identify a communication method for decision making teams, such as WebPaging. 
● Determine and communicate how leaders and frontline providers will 
communicate with DMTs. 
● Regularly attend Incident Command meetings. 
● Report to the Incident Commander (or designee) on the actions of the SRATT. 
● Collaborate with facilities, as necessary, regarding the operations of their 
SRATTs or similar bodies. 
● Collaborate with geographically nearby facilities regarding the operations of their 
SRATTs or similar bodies, including the ethical frameworks and clinical 
standards upon which their decisions are being made. 
In the event healthcare organizations experience a surge of patients to such an 
extent that triage standards of care are implemented, and allocation decisions must be 
made, the SRATT Chair (or designee) should: 
● Notify decision making teams of their position in the on-call schedule, the 
duration over which the on-call schedule is in force, and the expectations of each 
team. 
● Procure explicit written authorization from the Incident Commander (or designee) 
to implement allocation decision making as described in this document. 
● Request additional staff from hospital leadership to support the functioning of 
DMTs. 
● Implement a regularly occurring operations huddle for the SRATT, which may be 
virtual. 
● Identify operational indicators to determine when triage standards of care are 
likely to be suspended. 
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 In the event the SRATT’s decision making teams are implemented, the SRATT 
Chair shall schedule a mandatory debrief for all SRATT members no later than 48 hours 
after the conclusion of the last DMT’s work, which may be virtual. 
3. Membership 
Academic literature​6​ and allocation plans from other jurisdictions​7​ state that 
SRATTs should be multidisciplinary bodies. The membership of the SRATT should 
necessarily be fluid in the setting of a crisis. The following roles (and more, if necessary) 
should be filled to the extent possible. For each role, a primary and secondary member is 
identified by leaders to be approved by the Incident Commander (or designee), as 
appropriate. 
● Chair: ​This individual should be the hospital CMO (or designee) 
● Critical Care Representative: ​This individual must be a physician with expertise 
in critical care, pulmonology, or internal medicine. 
● Trauma Representative:​ This individual must be a physician with expertise in 
trauma surgery. 
● Infection Control Representative:​ This individual must be either a physician or 
other employee with expertise in infection control and/or infectious diseases. 
● Emergency Medicine Representative: ​This individual must be a physician with 
expertise in emergency medicine. 
● Hospital Medicine Representative:​ This individual must be a physician with 
expertise in internal medicine or hospital medicine. 
● Nursing Leadership Representative: ​This individual must be a nursing 
manager, with a preference for expertise in critical care nursing. 
● Respiratory Care Representative:​ This individual must have expertise in 
respiratory therapy. 
● Palliative Care Representative:​ This individual must be a physician with 
expertise in palliative care. 
● Clinical Ethics Representative: ​This individual must have expertise in clinical 
bioethics. 
● Pharmacy Representative:​ This individual must have expertise in clinical 
pharmacy, preferably with expertise in operations and utilization. 
● Social Work Representative:​ This individual must have expertise in social work. 
● Spiritual Services Representative:​ This individual must have expertise in 
multi-faith, non-sectarian spiritual care in healthcare settings. 
● Community Representative:​ This individual must be an Ethics Advisory 
Committee community member. 
 If the volume of allocation decisions and related work is high, the primary and 
secondary members should be required to rotate to the best of their availability. Members 
may fill a primary and secondary role but neither two primary nor two secondary roles. 
4. Ethical Framework 
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 Academic literature,​8​ emergency preparedness plans from Massachusetts and 
other jurisdictions,​9​ and professional society guidelines​10​ all agree that ethical allocation 
of scarce resources in crisis conditions should be supported by an explicit ethical 
framework. The SRATT is responsible for developing, vetting, and approving the ethical 
framework that supports its work prior to the implementation of allocation decision 
making. 
An ethical framework supports the SRATTs structure, function, and operations. In 
times of crisis, allocation decisions rest on the principles of minimizing mortality: 
allocation decisions aim to minimize overall mortality by finding the right balance 
between overtriage and undertriage. Ethical allocation decisions are also based upon the 
principle of harm reduction; a duty to care; principles of justice, fairness, and equity; 
transparency; proportionality; and other principles as delineated in the ​Guidelines​ above. 
Policies already under effect across healthcare organizations will be helpful in 
supporting ethical medical decision making under normal and surge conditions prior to 
the implementation of triage standards of care. These include: 
● Healthcare Decisions: Consent and Refusal of Treatment. 
● Non-Beneficial and/or Harmful Treatments. 
● Organizational Ethics. 
● Palliative Sedation Therapy. 
5. Clinical Algorithms 
 Allocation decisions made by the SRATT should be supported by clinical 
algorithms that are vetted and approved by appropriate subject matter experts. The 
SRATT is responsible for vetting these algorithms in as timely a manner as possible 
based on anticipated need.  
6. Educational Materials 
 As needed, the SRATT should develop educational materials for leaders, frontline 
healthcare providers, staff, and other stakeholders explaining allocation decision making 
in a crisis setting, including the ethical framework and clinical algorithms that support 
decision making. Educational materials must be vetted and approved by the Incident 
Commander (or designee). Approved educational materials should become appendices to 
this document. 
7. Personnel 
Work by additional personnel may be needed to be included to meet the above 
goals, such as a project manager, quality analyst, or Public Affairs. The SRATT Chair (or 
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 designee) may request temporary personnel assignments from Incident Command as 
needed. 
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 APPENDIX D: SCARCE RESOURCE ALLOCATION TRIAGE TEAM 
DISCIPLINARY MEMBERSHIP ROSTER AND DECISION MAKING TEAMS 
Role Name Primary or Secondary 
Chair  Primary 
Vice Chair  Secondary 
Critical Care Representative  Primary 
Critical Care Representative  Secondary 
Trauma Representative  Primary 
Trauma Representative  Secondary 
Surgery 1 Representative  Primary 
Surgery 1 Representative  Secondary 
Surgery 2 Representative  Primary 
Surgery 2 Representative  Secondary 
Surgery 3 Representative  Primary 
Surgery 3 Representative  Secondary 
Surgery 4 Representative  Primary 
Surgery 4 Representative  Secondary 
Surgery 5 Representative  Primary 
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 Surgery 5 Representative  Secondary 
Surgery 6 Representative  Primary 
Surgery 6 Representative  Secondary 
Infection Control Representative  Primary 
Infection Control Representative  Secondary 
Endocrinology Representative  Primary 
Endocrinology Representative  Secondary 
Gastroenterology Representative  Primary 
Gastroenterology Representative  Secondary 
Emergency Medicine 
Representative 
 Primary 
Emergency Medicine 
Representative 
 Secondary 
Hospital Medicine Representative  Primary 
Hospital Medicine Representative  Secondary 
Nursing Leadership 
Representative 
 Primary 
Nursing Leadership 
Representative 
 Secondary 
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 Bedside Nursing Representative  Primary 
Bedside Nursing Representative  Secondary 
Respiratory Care Representative  Primary 
Respiratory Care Representative  Secondary 
Behavioral Health Representative  Primary 
Behavioral Health Representative  Secondary 
Heart and Vascular 
Representative 
 Primary 
Heart and Vascular 
Representative 
 Secondary 
Hematology/Oncology 
Representative 
 Primary 
Hematology/Oncology 
Representative 
 Secondary 
Neurology Representative  Primary 
Neurology Representative  Secondary 
Palliative Care Representative  Primary 
Palliative Care Representative  Secondary 
Clinical Ethics Representative  Primary 
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 Clinical Ethics Representative  Secondary 
Pharmacy Representative  Primary 
Pharmacy Representative  Secondary 
Risk Management Representative  Primary 
Risk Management Representative  Secondary 
Social Work Representative  Primary 
Social Work Representative  Secondary 
Spiritual Services Representative  Primary 
Spiritual Services Representative  Secondary 
Patient Relations Representative  Primary 
Patient Relations Representative  Secondary 
Community Hospitals 
Representative 
 Primary 
Community Hospitals 
Representative 
 Secondary 
Community Representative  Primary 
Community Representative  Secondary 
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 DMT1:​ Surgery 1, Infection Control, Nursing Leadership 
DMT2: ​Surgery 2, Endocrinology, Pharmacy 
DMT3:​ Surgery 3, Gastroenterology, Social Work 
DMT4:​ Surgery 4, Hospital Medicine, Spiritual Services 
DMT5:​ Surgery 5, Behavioral Health, Patient Relations 
DMT6:​ Surgery 6, Heart and Vascular, Bedside Nursing 
DMT7:​ Hematology/Oncology, Neurology, Risk Management 
DMT8:​ Palliative Care, Community Hospitals, Clinical Ethics 
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 APPENDIX E: POLICY ON ALLOCATION OF SCARCE CRITICAL 
RESOURCES DURING A PUBLIC HEALTH EMERGENCY 
 
Executive Summary 
This document provides guidance to organizational leadership and frontline 
healthcare professionals for the triage of critically ill patients when a public health 
emergency creates demand for critical care resources (e.g., ventilators, critical care beds, 
etc.) that outstrips available supply. It distinguishes two phases of response to crisis 
conditions, ​surge​, which is a time for preparation that precedes actual crisis, and ​crisis​, 
when a regional-level authority has declared an emergency.  
The allocation framework under both conditions is grounded in ethical obligations 
that include the duty to care, duty to steward resources, distributive and procedural 
justice, reciprocity, and transparency (Section 1). It is consistent with existing public 
health ethics frameworks​1​ and recommendations for how to allocate scarce critical care 
resources during a public health emergency.​2​ From this ethical framework, a structure for 
supporting scarce resource allocation triage teams (Section 2) and a fair decision making 
process follow (Section 3). The process is designed to be attentive to the traumas likely to 
follow from widespread allocation decision making across healthcare organizations, and 
especially for frontline providers, decision makers, and patients (Section 4), including 
scripting for communicating allocation decisions with loved ones (Section 5) and a 
mechanism for allowing stakeholders to appeal allocation decisions (Section 6). 
 
1. Ethical Framework 
It is imperative that the teams who take on the awesome task of allocating scarce 
critical care resources are supported by an explicit and comprehensive ethical framework. 
Healthcare organization’s approach should rest on these principles: 
Duty to Care 
Healthcare professionals have a duty to care, even at personal risk. This includes a 
commitment to delivering the best care possible given the available resources. In a crisis, 
every patient should receive compassionate care, whether aimed at maximizing survival 
or supporting a dignified death. 
Duty to Steward Resources  
In crisis, all resources are potentially scarce, and all clinicians have a duty to 
protect them. All resources should be carefully allocated according to their known 
scarcity, likelihood of renewal, and the extent to which they can be replaced or reused. 
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 Distributive and Procedural Justice 
A system of allocation during crisis must be applied consistently and broadly, to 
maximize the chances of fairness and minimize the influence of biases such as ageism, 
sexism, racism, or ableism. Allocation decisions should seek to support access to care for 
all, regardless of their insurance status, and especially the most vulnerable or those who 
suffer disproportionately.  
Reciprocity  
Healthcare professionals, by virtue of the healing relationships they support 
through their work, may be justly given preference for scarce critical care resources under 
some circumstances. 
Transparency  
To the extent practically feasible, allocation plans should be communicated as 
efficiently, widely, and comprehensively as possible across the health system and moral 
community, inclusive of government agencies, nearby healthcare facilities, staff, patients, 
and other stakeholders. Such transparency is likely to minimize actual and vicarious 
trauma to patients, loved ones, staff, and members of the public after the crisis has 
abated. 
2. Creation of Scarce Resource Allocation Triage Teams 
Facilities across healthcare organizations have different levels of care, bed sizes, 
staffing, and leadership cultures. In real time, the need to triage will arise and present 
itself differently for these reasons. This section provides guidance on how to create local 
scarce resource allocation triage teams (SRATT) during surge conditions that ensures a 
single approach across the enterprise, while also allowing for tailored local 
implementation during crisis conditions. ​It is important to emphasize that patients’ 
treating physicians should not make allocation decisions​; ​a triage team with 
expertise and training in the allocation framework should make allocation decisions​. 
The separation of the triage role from the clinical role is intended to ensure quality 
decision making, enhance objectivity, avoid conflicts of commitments, and minimize 
moral trauma and distress. 
Scarce Resource Allocation Triage Teams (SRATT) 
The SRATT has two basic functions: 
1. To develop guidance for ethically allocating scarce healthcare resources and 
supporting healthcare professionals in a crisis circumstance. 
2. To implement allocation methods, making choices to provide, withhold, or 
withdraw scarce resources from patients in a crisis. 
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 When developing guidance and supporting healthcare professionals,​ the SRATT 
requires a quorum to operate, defined as one third of all primary or secondary 
members​, as described below. In this function, which is anticipated to occur prior to (and 
potentially during) implementing triage standards of care, the SRATT meets regularly to 
work on developing and agreeing upon the ethical framework for decision making, 
clinical algorithms for triage, educational materials and methods, and other business as 
needs arise. All SRATT business of this nature may be performed remotely, including 
any voting required to ratify committee actions. 
When making allocation decisions, the SRATT operates in smaller groups, 
called decision making teams (DMTs) of at least two individuals, preferably three, 
one of whom must always be a physician.​ As long as circumstances allow it, preference 
should be to staff SRATT-DMTs solely by physicians. 
Allocation decisions are decisions to provide or withhold a resource (e.g., a 
hospital bed, ventilator, etc.) to or from a patient when resources are scarce, meaning that 
the volume of patients in need of the resource is far greater than the amount of the 
resource available. ​Allocation decisions are made by the SRATT, in smaller groups, 
using guidelines endorsed by the SRATT and approved institutionally, not by 
individual healthcare professionals at the bedside. ​In this way, frontline healthcare 
providers are spared the moral burden of having to make allocation decisions. 
In the event the hospital anticipates a surge of patients to such an extent that triage 
standards of care are likely to be implemented and allocation decisions likely to be 
necessary, the SRATT Chair (hospital CMO or designee) should designate one or more 
members of the SRATT to: 
● Group members into sets of three to form decision making teams (DMTs). 
● Coordinate an on-call schedule for DMTs, such that they are available 24 hours a 
day, 7 days a week. 
● Identify a communication method for decision making teams, such as WebPaging. 
● Determine and communicate how leaders and frontline providers will 
communicate with DMTs. 
● Regularly attend Incident Command meetings. 
● Report to the Incident Commander (or designee) on the actions of the SRATT. 
● Collaborate with facilities, as necessary, regarding the operations of their 
SRATTs or similar bodies. 
● Collaborate with geographically nearby facilities regarding the operations of their 
SRATTs or similar bodies, including the ethical frameworks and clinical 
standards upon which their decisions are being made. 
● Agree upon a framework at least 24 hours in advance so that triage physicians can 
make informed decisions. 
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 In the event that healthcare organizations experience a surge of patients to such an 
extent that triage standards of care are implemented, and allocation decisions must be 
made, the SRATT Chair (or designee) should: 
● Notify decision making teams of their position in the on-call schedule, the 
duration over which the on-call schedule is in force, and the expectations of each 
team. 
● Procure explicit written authorization from the Incident Commander (or designee) 
to implement allocation decision making as described in this document. 
● Request additional staff from hospital leadership to support the functioning of 
DMTs. 
● Implement a regularly occurring, mandatory operations huddle for the full 
SRATT, which may be virtual. 
● Identify operational indicators to determine when triage standards of care are 
likely to be suspended. 
In the event the SRATT’s decision making teams are implemented, the SRATT 
Chair shall schedule a mandatory debrief for all SRATT members no later than 48 hours 
after the conclusion of the last DMT’s work, which may be virtual. 
Executive Support 
Local senior leaders, including physicians, are responsible for appointing 
members of DMTs, preferably no later than during surge conditions. A roster of approved 
triage committee members should be maintained that is large enough to ensure that they 
will always be available on short notice; that team members work in shifts lasting no 
longer than 13 hours; that team members will have sufficient rest periods between shifts; 
and that the rationale for all allocation decisions is comprehensively documented in the 
medical record and in ways that facilitate rapid, real-time reporting as described herein. 
Senior leadership should provide the triage team with support staff to collect, analyze, 
and distribute information about the team’s work. The support staff member must be 
allocated appropriate time and provided with appropriate computer and IT support to 
maintain updated databases of patient priority levels and scarce resource usage (total 
numbers, location, and type). ​Leadership can reformat the guidance given here to the 
extent necessary to rapidly get approval by local policy making mechanisms, 
including making minor revisions or adding addenda to further specify workflows 
aligned with local conditions. 
Triage Mechanism 
During crisis conditions, the triage team should use an explicit allocation 
framework to determine priority scores of all patients eligible to receive scarce critical 
care resources. For patients already being supported by a scarce resource, the evaluation 
should include reassessment to evaluate for clinical improvement or worsening at 
pre-specified intervals. The triage officer should review the comprehensive list of priority 
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 scores for all patients and should communicate with the clinical teams immediately after 
a decision is made regarding allocation or reallocation of a critical care resource. 
Quality Assessment, Oversight, and Reporting 
As widespread acute care triage would be novel , if this policy is implemented 
and DMTs perform allocation decision making in multiple institutions over a prolonged 
time period, Incident Command is responsible for rapidly developing and deploying a 
method of tracking the implementation of this policy, defining and describing quality 
performance of DMTs, and longitudinally analyzing their performance. Under such a 
scenario, Incident Command is responsible for allocating a quality analyst or individual 
with equivalent capabilities, to be overseen by the local CMO, to process the data 
emerging from local triage team activities, so that it can be regularly reported to Incident 
Command for the purposes of oversight. 
3. Allocation Process for Scarce Critical Care Resources 
Under crisis conditions only, a clinical assessment algorithm is coupled with a 
decision-making process to produce an allocation framework for making initial triage 
decisions for patients who present with illnesses that typically require critical care 
resources. ​The framework must be applied to all patients presenting with critical 
illness, not simply those with the disease or disorders that arise from the public 
health emergency.​ This process involves several steps, detailed below:  
 
A. Calculating each patient’s priority score based on the multi-principle allocation 
framework. 
B. Assigning each patient to a priority group (Red, Green, Yellow, or Blue). 
C. Determining, on a daily basis, how many priority groups will receive access to 
critical care interventions. 
D. Deciding, as needed, which patients will receive access to critical care resources 
in the setting of a tie within a priority group receiving daily priority. 
In many crisis conditions, first responders and bedside clinicians should perform 
the immediate stabilization of any patient in need of critical care, as they would under 
normal circumstances. Along with stabilization, temporary ventilatory support may be 
offered to allow the triage officer to assess the patient for critical resource allocation. 
Every effort should be made to complete the initial triage assessment within 90 
minutes of the recognition of the need for critical care resources. 
Under some crisis conditions, the duty to care may be offset by other duties, such 
as the duty to steward resources like personal protective equipment. Under these 
conditions, it may be appropriate to issue a directive across a facility to attempt 
immediate stabilization, as one would under normal conditions, but to limit escalation of 
emergency care such that no cardiopulmonary resuscitation be performed upon patients 
who would receive it under normal circumstances in an emergency department. Whether 
such conditions exist should be determined by senior hospital leaders, including 
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 physicians and senior vice presidents, in collaboration with the triage team. ​If this 
scenario were to be put into effect, this policy would be communicated in a transparent 
manner to stakeholders as it would be a departure from non-crisis standard of care.  
Step 1: Priority Score Calculation 
During crisis conditions, patients who are more likely to survive with intensive 
care are prioritized over patients who are less likely to survive with intensive care using 
an ​MPS Score​. Patients who do not have serious comorbid illness are given priority over 
those who have illnesses that limit their life expectancy. As summarized in Table 1, the 
sequential organ failure assessment (SOFA/pSOFA) score is used to characterize 
patients’ prognosis for hospital survival. The presence of life-limiting comorbid 
conditions is also used to characterize patients’ longer-term prognosis. Points are 
assigned according to the patient’s (p)SOFA score (range from 2 to 4 points); and the 
presence of comorbid conditions (2 points for major life-limiting comorbidities, 4 points 
for severely life-limiting comorbidities (Table 2)). These points are then added together 
to produce a total priority score, which ranges from 2 to 8. Lower scores indicate higher 
likelihood to benefit from critical care; ​priority should be given to those with lower 
scores​. 
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 Table 1. Multi-Principle Strategy to Allocate Critical Care/Ventilators During a 
Public Health Emergency 
 
  
Purpose 
  
Clinical 
Assessment 
MPS Point Scoring System* 
1 2 3 4 
Prognosis for 
Hospital 
Survival 
(p)SOFA <6 6-9 10-12 >12 
  MPS (p)SOFA 
Score 
        
Prognosis for 
Long Term 
Survival 
Assessment of 
Comorbidities 
None 1 Major 
Comorbidity 
>1 Major 
Comorbidity 
Indicator for 
Mortality 
within One 
Year 
  MPS 
Comorbidity 
Score 
        
  MPS Total         
(p)SOFA = (pediatric)Sequential Organ Failure Assessment 
* Patients with the lowest cumulative score are prioritized for receiving scarce critical care resources during 
crisis conditions. 
Prognostication under normal circumstances is difficult. However, under crisis 
conditions, it is likely that physicians will be able to more accurately prognosticate about 
a patients’ long term chances of term survival with meaningful recovery, because the 
generalized resource scarcity entails that fewer people are likely to receive adequate 
healthcare to recover under crisis conditions than under normal conditions. Therefore, 
during crisis, more people will be likely to have a lower chance of long term survival 
than in normal conditions. Yet prognostication requires discernment and clinical 
judgment. The following examples of major comorbid conditions and indicators of 
morbidity within one year used to score patients in Step 1 should be adapted to local 
conditions by DMTs using the best available evidence.​3 
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 Table 2. Examples of Major Comorbidities and Indicators of Morbidity Within One 
Year Used for Scoring 
Examples of Major Comorbidities 
(associated with significantly decreased 
long-term survival) 
Examples of Severely Life Limiting 
Comorbidities (associated with survival  
< 1 year) 
○ Moderate Alzheimer’s disease or related 
dementia 
○ Malignancy with a < 10 year expected 
survival 
○ New York Heart Association (NYHA) Class 
III heart failure 
○ Moderately severe chronic lung disease 
(e.g., COPD, IPF)  
○ End stage renal disease 
○ Severe, inoperable multivessel CAD 
○ Progressive neurologic or neuromuscular 
disease with significant disability 
○ Severe or progressive metabolic disorder 
○ Cirrhosis with history of decompensation 
○ End-stage renal disease in patients < 75 
○ Severe Alzheimer’s disease or related 
dementia 
○ Metastatic cancer receiving only palliative 
treatments  
○ New York Heart Association (NYHA) Class 
IV heart failure 
○ Severe chronic lung disease with FEV1 < 25% 
predicted, TLC < 60% predicted, or baseline 
PaO2 < 55mm Hg 
○ Cirrhosis with MELD score ≥20 
○ Unwitnessed cardiac arrest with delayed or no 
cardiopulmonary resuscitation  
○ Known severe chromosomal abnormality or 
genetic syndrome, such as trisomy 13 or 18 
○ End stage/ severe neurologic or neuromuscular 
disease (SMA type 1 or similar) 
○ End stage pulmonary hypertension 
DMTs are expected to evaluate, revise, and circulate their lists of major comorbidities and indicators of 
morbidity within one year during their operations and regular report outs at the local and regional levels. 
Step 2: Assign Patients to Color-Coded Priority Groups 
Once a patient’s MPS Score is calculated using the system described in Table 1, 
each patient is assigned to a color-coded triage priority group (Table 3). This must be 
noted clearly in the medical record by the attending physician. Using these priority 
groups enables DMTs to create operationally clear priority groups to receive critical care 
resources, according to their MPS score. For example, individuals in the red group have 
the best chance to benefit from critical care interventions and should therefore receive 
priority over all other groups in crisis conditions. The orange group has intermediate 
priority and should receive critical care resources if there are available resources after all 
patients in the red group have been allocated critical care resources. The yellow group 
has lowest priority and should receive critical care resources if there are available 
resources after all patients in the red and orange groups have been allocated critical care 
resources. 
It is important to note that all patients should be eligible to receive critical care 
beds and services regardless of their priority score. The availability of critical care 
resources should determine how many eligible patients will receive critical care. Patients 
who are not allocated critical care, mechanical ventilation, or both should receive medical 
care that includes intensive symptom management and psychosocial support. They 
should also be reassessed at least daily to determine if changes in resource availability or 
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 their clinical status warrant provision of critical care services. Where available, specialist 
palliative care teams should be available for consultation. Where palliative care 
specialists are not available, the treating clinical teams should provide primary palliative 
care. 
Table 3. Color-Coded Priority Groups Based on Multi-Principle Scoring (MPS) 
Priority Assignments Based on MPS System to Assign Priority Category 
Level of Priority and Code Color Priority Score from MPS 
System 
RED 
Highest Priority for Scarce Resource 
(Immediate Need for Critical Interventions) 
 
Priority Score 2-4 
GREEN 
High Priority for Scarce Resource 
(No Immediate Need for Critical Interventions) 
 
Priority Score 2-4 
YELLOW 
Low Priority for Scarce Resource 
(Continued Medical Management) 
 
Priority Score 5-6 
BLUE 
Lowest Priority for Scarce Resource 
(Comfort Care) 
 
Priority Score 7-8 
The daily operations of DMTs should include reconciling the amount of available 
scarce critical care resources with recent trends in the volume of patients who present that 
are likely to need assessment for critical care. Each day that allocation decisions are 
anticipated, a member of the DMT should produce an easily readable grid diagram to 
indicate which MPS-tiers are likely to receive scarce critical care resources, so that 
hospital and physician leaders are able to communicate with appropriate staff which MPS 
groups are unlikely to receive critical care resources. Yet, this communication must not 
supersede decision making by the DMTs, as described herein.  
 
Step 3: Reassessment 
Under crisis conditions, the triage team should receive periodic reassessments of 
patients who are receiving critical care services by the patient’s attending physician, in 
order to determine whether it is appropriate to reallocate scarce critical care resources to a 
patient in a higher priority MPS group. The ethical justification for such reassessment is 
that, in a public health emergency when there are not enough critical care resources for 
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 all, the goal of maximizing population outcomes would be jeopardized if patients who 
were determined to be unlikely to survive were allowed indefinite use of scarce critical 
care services. In addition, periodic reassessments lessen the chance that arbitrary 
considerations, such as when an individual develops critical illness, unduly affect 
patients’ access to treatment.  
All patients who are allocated critical care services should be allowed a 
therapeutic trial of a duration to be determined by the clinical characteristics of the 
disease. The decision about trial duration should ideally be made as early in the public 
health emergency as possible, when data becomes available about the natural history of 
the disease. The trial duration should be modified as appropriate as subsequent relevant 
data emerges.  
Periodic reassessments of patients receiving critical care resources should involve 
re-calculating (p)SOFA score, assessing changes in the patient’s clinical trajectory, and 
documenting this in the medical record. Patients showing improvement should continue 
to receive their allocated critical care resources until the next assessment. If there are 
patients in the queue for critical care services, then patients who, upon reassessment, 
show substantial clinical deterioration as evidenced by worsening (p)SOFA scores or 
overall clinical judgment, then the triage team should determine whether it is appropriate 
to reallocate the scarce resources they are receiving. Although patients should generally 
be given the full duration of a trial, if patients experience a precipitous decline (e.g., 
refractory shock and disseminated intravascular coagulation) or a highly morbid 
complication (e.g., massive stroke) that portends a very poor prognosis, the triage team 
may make a decision before the completion of the specified trial length that the patient is 
no longer eligible for critical care treatment. 
Patients who are no longer eligible for critical care treatment should receive 
medical care including intensive symptom management and psychosocial support. Where 
available, specialist palliative care teams should be available for consultation. 
4. Additional Considerations 
While allocation decision making is not unprecedented, its widespread 
implementation across civil society would be. Therefore, it is impossible to predict what 
other ethical or clinical considerations would warrant consideration in the event triage in 
such a scenario. The following additional considerations, as well as others not specified 
here, should be considered to guide allocation decision making in the event of a 
widespread, prolonged, public health emergency. In the event that any of these additional 
considerations are appealed to as reasons for making allocation decisions, they should be 
explicitly documented, recorded, and integrated into the normal reporting by triage 
committees described above. 
Resolving “Ties” Between Patients Within MPS Groups 
In the event of “ties” in priority scores between patients and not enough critical 
care resources for all patients with the lowest priority score, careful and critical analysis 
by the SRATT Chair (or designee) should be performed. To aid in the process of these 
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 determinations, ​supplemental metrics (i.e., scoring systems) should be introduced ​that 
take into consideration the following. 
● Likelihood of​ long-term net clinical ​benefit​. 
● Quality-adjusted ​life years​ (QALY). 
● Urgency​ of need. 
● Duration​ of benefit. 
● Long-term ​quality​ ​of life. 
● Availability of resources​ required to secure long-term benefit. 
Categorical Exclusion Criteria 
A central feature of this allocation framework is that it avoids the use of 
categorical exclusion criteria to indicate individuals who should not have access to 
critical care services under any circumstances during a public health emergency. 
Categorical exclusion may be interpreted by the public that some groups are “not worth 
saving,” leading to perceptions of unfairness. In a public health emergency, public trust 
will be essential to ensure compliance with restrictive measures. Thus, an allocation 
system should make clear that all individuals are “worth saving.” One way to do this is to 
keep all patients who would receive mechanical ventilation during routine clinical 
circumstances eligible but allow the availability of ventilators to determine how many 
eligible patients receive it.  
It should be noted that there are some conditions that lead to immediate or 
near-immediate death despite aggressive therapy such that during routine clinical 
circumstances clinicians do not provide critical care services (e.g., cardiac arrest 
unresponsive to appropriate ACLS, overwhelming traumatic injuries, massive intracranial 
bleeds, intractable shock). During a public health emergency, the duty to care and duty to 
steward resources align in underscoring physicians’ obligations to make clinical 
judgments about the appropriateness of critical care use, based on the same criteria one 
would apply during normal clinical practice. Similarly, during crisis conditions, the duty 
to care, duty to steward resources, and commitment to procedural justice also align in 
support of physicians’ obligations to appropriately respond to loved ones’ requests for 
potentially inappropriate treatment, which may include refusing such requests after a fair 
procedure for responding to them has been implemented.​4-8 
Reciprocity: Prioritizing Those Who are Central to the Public Health Response 
Individuals who perform tasks that are vital to the public health response, 
including all those whose work directly supports the provision of acute care to others, 
should be given heightened priority. This category should be broadly construed to include 
those individuals who play a critical role in the chain of treating patients and maintaining 
societal order. The specifics of how to operationalize this consideration should depend on 
the exact nature of the public health emergency. Options include subtracting points from 
the priority score for these individuals or using it as a tiebreaker criterion. 
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 5. Communicating Allocation Decisions 
Although the authority for allocation decisions rests with the SRATT, there are 
several potential strategies to communicate allocation decisions to patients and families. 
Upon identifying that a facility is likely to experience surge conditions, it is incumbent 
upon Incident Command to support the local CMO in developing and distributing 
scripting to support appropriate communication by SRATT members that fits each of the 
following envisioned communication scenarios.  
The triage officer (TO) or delegated SRATT member should first inform the 
affected patient’s attending physician about the allocation decision prior to 
collaboratively determining the best approach to inform the individual patient and family. 
Options for who should communicate the decision include (1) a designated member of 
the SRATT, a TO, the local CMO, or a combination thereof should communicate triage 
decisions to patients and families of patients who are not, for whatever reason, candidates 
for life-sustaining medical treatments. 
The best approach will likely depend on a variety of local factors, including the 
dynamics of the individual physician-patient-family relationship and the preferences of 
the attending physician. In general, communications about allocation decisions should 
explain the severity of the patient’s condition in an emotionally supportive way, explain 
the implications of those facts in terms of the allocation decision, and explain the 
palliative therapies available for the patient. It should also be emphasized that the 
allocation decision was not made by the attending physician but is instead one that arose 
from the extraordinary emergency circumstances and reflected a public health decision. It 
may also be appropriate to explain the medical factors that informed the decision, as well 
as the factors that were not relevant (e.g., race, ethnicity, insurance status, perceptions of 
social worth, immigration status, etc.). Palliative care clinicians, social workers, and 
chaplains should be made available to provide ongoing emotional support to the patient 
and family.  
During surge conditions, in anticipation of a crisis requiring widespread triage, 
personnel should be allocated by appropriate leaders at the regional or system level to 
develop communication for dissemination across all spans and layers, including 
appropriately to stakeholders outside of the healthcare organization, such as 
governmental agencies, the media, and the public. These efforts cannot be the 
responsibility of members of local DMTs, as they will be preparing for the work of 
making allocation decisions. 
6. Appeals Process for Allocation Decisions 
In the event a patient’s loved one or healthcare professional challenges individual 
allocation decisions, an appeals mechanism is required to resolve such disputes. On 
practical grounds, different appeals mechanisms are needed for the initial decision to 
allocate a scarce resource among individuals, none of whom are currently using the 
resource, and the decision to withdraw a scarce resource from a patient who is clinically 
deteriorating.  
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 For the initial allocation decision, it is recommended that the only permissible 
appeals are those based on a claim that an error was made by the triage team in the 
calculation of the priority score. The process of evaluating the appeal should consist of 
the triage team verifying the accuracy of the priority score calculation by recalculating 
the score.  
Decisions to withdraw a scarce critical care resource from a patient who is already 
receiving it may cause heightened moral concern and also depend on more clinical 
judgment than initial allocation decisions. Therefore, a more robust appeal process should 
be implemented for them, so long as the conditions of allocation decision making permit 
doing so. If appeals take up sufficient time that they impede other awaiting allocation 
decisions, then they should be limited only to verifying that the priority scoring was 
accurately calculated by recalculating the score. Time permitting, the more robust appeals 
process includes: 
 
A. The appeal should be immediately brought to the SRATT. 
B. The individuals who are appealing the allocation decision should explain their 
disagreement with the decision. An appeal may not be brought based on an 
objection to the overall allocation framework.  
C. The SRATT Chair (or designee) should explain the grounds for the allocation 
decision that was made. 
D. The appeals process must occur quickly enough that the appeals process does not 
harm patients who are in the queue for the scarce resource. If this is untenable, 
simple verification priority scoring should be offered.  
E. An independent subgroup of the SRATT, removed from the original calculation, 
should recalculate the score so as to preclude bias. 
F. The decision of the SRATT subgroup should be final. 
G. Periodically, the SRATT should retrospectively assess whether the review process 
is consistent with effective, fair, and timely application of the allocation 
framework. 
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 APPENDIX F: SCARCE RESOURCE ALLOCATION PROTOCOL TRIAGE 
ALGORITHMS 
 
Algorithm 1: Initial Triage Determination of Allocation of Scarce Resources 
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 Algorithm 2: Re-evaluation of All Patients  
  
This will include patients already receiving critical care prior to activation of the 
allocation framework. 
 
*​The appropriate time period for reassessment should depend on the patient’s specific 
circumstances; suggested at least every 24 hours, but there may be circumstances that 
warrant more rapid reassessment or a longer trial of critical care prior to reassessment  
  
+Significant deterioration should be determined based on a combination of clinical 
judgment and (p)SOFA score. 
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 Algorithm 3: Rapid reassessment of patients emergently triaged to critical care after 
initiation of allocation framework  
  
This algorithm applies to situations in which patients do not receive a triage score before 
being triaged to critical care (e.g., patients intubated in the field, patients emergently 
intubated in the emergency department, patients with no information in the electronic 
medical record, trauma patients stabilized in the ED prior to ability to triage).  
 
 
 
 
 
*While providing intensive symptom management and psychosocial support. 
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